RESULT_COUNT: 478,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
RDY,RDY:US,BBG000NJ96L6,DEADLINE TUESDAY: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-10-21 03:31:00 +0000,https://finance.yahoo.com/news/deadline-tuesday-lundin-law-pc-033100169.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 20, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (''Dr. Reddy's'' or the ''Company'') ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-10-21 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddy-96-hour-deadline-025000612.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against Dr."
RDY,RDY:US,BBG000NJ96L6,"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017",2017-10-20 14:44:00 +0000,https://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-144400265.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 20, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-10-20 13:44:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-134400193.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 20, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Ltd. - RDY,2017-10-19 21:20:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-212000804.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 19, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" or the ""Company"") (NYSE: ..."
RDY,RDY:US,BBG000NJ96L6,"RDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-10-19 15:41:00 +0000,https://finance.yahoo.com/news/rdy-shareholder-alert-law-offices-154100807.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 19, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey ..."
RDY,RDY:US,BBG000NJ96L6,5-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-19 14:23:00 +0000,https://finance.yahoo.com/news/5-day-deadline-khang-khang-142300479.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 19, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 24th Lead Plaintiff Deadline in Securities Class Action Against Dr. Reddy’s Laboratories Limited (RDY)",2017-10-19 14:10:00 +0000,https://finance.yahoo.com/news/scott-scott-attorneys-law-llp-141000238.html?.tsrc=rss,"Scott+Scott, Attorneys at Law, LLP , a national shareholder and consumer rights litigation firm, reminds investors that October 24th is the deadline for lead plaintiff motions in the securities class action against Dr. Reddy’s Laboratories Limited (“Dr."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Dr. Reddy's Laboratories Limited to Contact the Firm",2017-10-18 21:17:00 +0000,https://finance.yahoo.com/news/dr-reddys-investor-alert-faruqi-211700262.html?.tsrc=rss,"Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr. Reddy's Laboratories Limited of the October 24, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company."
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited,2017-10-18 19:52:00 +0000,https://finance.yahoo.com/news/equity-alert-goldberg-law-pc-195200937.html?.tsrc=rss,"LOS ANGELES , Oct. 18, 2017 /PRNewswire/ --  Goldberg Law PC , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. ..."
RDY,RDY:US,BBG000NJ96L6,"Glancy Prongay & Murray Reminds Investors of the October 24th Deadline in the Class Action Lawsuit Against Dr. Reddy’s Laboratories, Ltd. (RDY)",2017-10-18 19:06:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-reminds-investors-190600226.html?.tsrc=rss,"Glancy Prongay & Murray LLP  reminds investors of the October 24, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Dr."
RDY,RDY:US,BBG000NJ96L6,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-10-18 16:20:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-162000738.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 18, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,DEADLINE REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-10-18 14:47:00 +0000,https://finance.yahoo.com/news/deadline-reminder-lundin-law-pc-144700953.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 18, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-10-18 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddy-shareholder-alert-claimsfiler-025000757.html?.tsrc=rss,"NEW ORLEANS, Oct. 17, 2017-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 24, 2017 to file lead plaintiff applications in a securities class action ..."
RDY,RDY:US,BBG000NJ96L6,ONE WEEK DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-17 18:16:00 +0000,https://finance.yahoo.com/news/one-week-deadline-khang-khang-181600462.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 17, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) and Lead Plaintiff Deadline: October 24, 2017",2017-10-17 14:43:00 +0000,https://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-144300319.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 17, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Dr. Reddy's Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017 (RDY)",2017-10-17 14:36:00 +0000,https://finance.yahoo.com/news/klein-law-firm-notifies-investors-143600750.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 17, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr. Reddy's Laboratories Ltd. (NYSE: RDY) who purchased ..."
RDY,RDY:US,BBG000NJ96L6,UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-10-16 19:00:00 +0000,https://finance.yahoo.com/news/upcoming-deadline-lundin-law-pc-190000810.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 16, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") ..."
RDY,RDY:US,BBG000NJ96L6,"RDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-10-16 15:11:00 +0000,https://finance.yahoo.com/news/rdy-shareholder-alert-law-offices-151100110.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 16, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's to Release Q2 FY18 Results on October 31, 2017",2017-10-16 14:14:00 +0000,https://finance.yahoo.com/news/dr-reddys-release-q2-fy18-141400499.html?.tsrc=rss,"Dr. Reddy's Laboratories will announce results for the Second Quarter ended September 30, 2017 on Tuesday, October 31, 2017 after the Board Meeting."
RDY,RDY:US,BBG000NJ96L6,UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-14 03:10:00 +0000,https://finance.yahoo.com/news/upcoming-deadline-khang-khang-llp-031000034.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 13, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-10-14 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddy-shareholder-alert-former-025000415.html?.tsrc=rss,"NEW ORLEANS, Oct. 13, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 24, 2017 to file lead ..."
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - RDY,2017-10-13 21:45:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-214500562.html?.tsrc=rss,"NEW YORK , Oct. 13, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces filing of a class action lawsuit on behalf of purchasers of Dr. Reddy's Laboratories Ltd. (NYSE: RDY) ..."
RDY,RDY:US,BBG000NJ96L6,"DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) To Contact The Firm",2017-10-13 10:10:00 +0000,https://finance.yahoo.com/news/deadline-alert-brower-piven-reminds-101000598.html?.tsrc=rss,"STEVENSON, Md., Oct. 13, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
RDY,RDY:US,BBG000NJ96L6,DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-10-12 18:14:00 +0000,https://finance.yahoo.com/news/deadline-approaching-lundin-law-pc-181400891.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 12, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm",2017-10-11 21:26:00 +0000,https://finance.yahoo.com/news/dr-reddys-investor-alert-faruqi-212600575.html?.tsrc=rss,"NEW YORK, Oct. 11, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") (RDY) of the October 24, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.  The lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all those who purchased Dr. Reddy's securities between June 17, 2015 and August 10, 2017 (the ""Class Period"").  The case, Critchley v. Dr. Reddy's Laboratories Limited et al, No. 3:17-cv-06436 was filed on August 25, 2017."
RDY,RDY:US,BBG000NJ96L6,APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-11 20:49:00 +0000,https://finance.yahoo.com/news/approaching-deadline-khang-khang-llp-204900724.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 11, 2017 / Khang & Khang LLP (the ''Firm'') announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (''Dr. Reddy's'' or the ''Company'') (NYSE: ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-10-11 16:00:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-160000784.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 11, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-10 18:16:00 +0000,https://finance.yahoo.com/news/deadline-alert-lundin-law-pc-181600386.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 10, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) and Lead Plaintiff Deadline: October 24, 2017",2017-10-10 14:43:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144300596.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 10, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Dr. Reddy's Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017 (RDY)",2017-10-10 14:42:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-144200626.html?.tsrc=rss,"NEW YORK, NY /ACCESSWIRE / October 10, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr. Reddy's Laboratories Ltd. (NYSE: RDY) who purchased ..."
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-09 17:17:00 +0000,https://finance.yahoo.com/news/equity-alert-khang-khang-llp-171700911.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 9, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-10-09 14:25:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-142500525.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 9, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Marginally Higher After GST Relief",2017-10-09 07:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N3X3MIt3tFs/sensex-nifty-end-marginally-higher-after-gst-relief-20171009-00295,"Sensex, Nifty End Marginally Higher After GST Relief"
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-07 20:00:00 +0000,https://finance.yahoo.com/news/equity-alert-lundin-law-pc-200000894.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 7, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-10-07 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddy-shareholder-alert-claimsfiler-025000857.html?.tsrc=rss,"ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against Dr."
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-04 18:28:00 +0000,https://finance.yahoo.com/news/investor-alert-khang-khang-llp-182800542.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 4, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"RDY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-10-04 15:12:00 +0000,https://finance.yahoo.com/news/rdy-equity-alert-law-offices-151200749.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 4, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Rise As RBI Keeps Repo Rate Steady",2017-10-04 07:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1HOo61Emdvc/sensex-nifty-rise-as-rbi-keeps-repo-rate-steady-20171004-00306,"Sensex, Nifty Rise As RBI Keeps Repo Rate Steady"
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-03 19:47:00 +0000,https://finance.yahoo.com/news/shareholder-alert-lundin-law-pc-194700453.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 3, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ""Company"") ..."
RDY,RDY:US,BBG000NJ96L6,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-10-03 15:06:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-150600662.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 3, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex Up 190 Points In Early Trade; Nifty Rises Above 9,850",2017-10-03 00:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p8CUzx14Tbw/sensex-up-190-points-in-early-trade-nifty-rises-above-9850-20171003-00005,"Sensex Up 190 Points In Early Trade; Nifty Rises Above 9,850"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Up On Global Cues",2017-10-02 22:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N4K2CcBGaq8/sensex-nifty-seen-up-on-global-cues-20171002-01530,"Sensex, Nifty Seen Up On Global Cues"
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm",2017-10-02 21:27:00 +0000,https://finance.yahoo.com/news/dr-reddys-investor-alert-faruqi-212700214.html?.tsrc=rss,"Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr. Reddy's Laboratories Limited of the October 24, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company."
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-10-02 20:02:00 +0000,https://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-200200490.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 2, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017",2017-10-02 14:42:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144200998.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 2, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-09-30 03:34:00 +0000,https://finance.yahoo.com/news/investor-alert-lundin-law-pc-033400938.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-09-30 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddy-shareholder-alert-former-025000027.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against Dr."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Sevelamer Carbonate Tablets in the U.S. Market,2017-09-29 17:21:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-172100319.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has launched Sevelamer Carbonate Tablets, 800 mg, a therapeutic equivalent generic version of Renvela® Tablets, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-09-29 14:24:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-142400262.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 29, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Pare Early Gains To End Flat",2017-09-29 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iSYLqcqN_0M/sensex-nifty-pare-early-gains-to-end-flat-20170929-00291,"Sensex, Nifty Pare Early Gains To End Flat"
RDY,RDY:US,BBG000NJ96L6,"Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors and Encourages Investors to Contact the Firm (RDY)",2017-09-28 18:51:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-announces-filing-185100794.html?.tsrc=rss,"Glancy Prongay & Murray LLP  announces that a class action lawsuit has been filed on behalf of investors that purchased Dr. Reddy’s Laboratories, Ltd. securities between June 17, 2015 and August 10, 2017, inclusive ."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-09-28 16:36:00 +0000,https://finance.yahoo.com/news/important-equity-alert-khang-khang-163600586.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 28, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or ..."
RDY,RDY:US,BBG000NJ96L6,"RDY INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-09-28 14:57:04 +0000,https://finance.yahoo.com/news/rdy-investor-alert-law-offices-145704391.html?.tsrc=rss,"NEW YORK, Sept. 28, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Rebound On Eve Of F&O Expiry",2017-09-28 07:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uGsXTgFqjZA/sensex-nifty-rebound-on-eve-of-fo-expiry-20170928-00377,"Sensex, Nifty Rebound On Eve Of F&O Expiry"
RDY,RDY:US,BBG000NJ96L6,IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-09-27 18:27:00 +0000,https://finance.yahoo.com/news/important-equity-alert-lundin-law-182700244.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 27, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,Teva Reintroduces Generic Depo-Provera Injection in U.S.,2017-09-27 15:59:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XJ7OhFCSw-A/teva-reintroduces-generic-depo-provera-injection-in-us-cm851858,Teva Pharmaceutical Industries Ltd TEVA announced the reintroduction of the generic equivalent to Depo Prover Contraceptive Injection medroxyprogesterone acetate injectable suspension USP 150 mg mL in the United States indicated for the prevention of pregnancy With the reintroduction
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy’s Laboratories Ltd. (RDY) & Lead Plaintiff Deadline - October 24, 2017",2017-09-27 14:42:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144200727.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 27, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy’s Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 – RDY",2017-09-27 14:26:44 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-142644673.html?.tsrc=rss,"NEW YORK, Sept. 27, 2017-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy’ s Laboratories Ltd. ..."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-09-26 18:26:32 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-182632313.html?.tsrc=rss,"IRVINE, Calif., Sept. 26, 2017-- Khang & Khang LLP announces a securities class action lawsuit against Dr. Investors who purchased or otherwise acquired shares from June 17, 2015 through August 10, 2017, ..."
RDY,RDY:US,BBG000NJ96L6,"The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Dr. Reddy's Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017 (RDY)",2017-09-26 14:43:00 +0000,https://finance.yahoo.com/news/klein-law-firm-notifies-investors-144300189.html?.tsrc=rss,"NEW YORK, NY /ACCESSWIRE / September 26, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr. Reddy's Laboratories Ltd. (NYSE: RDY) who purchased ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Little Changed In Early Trade",2017-09-26 00:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/47fWtt_Lk3A/sensex-nifty-little-changed-in-early-trade-20170926-00009,"Sensex, Nifty Little Changed In Early Trade"
RDY,RDY:US,BBG000NJ96L6,"DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy’s Laboratories Ltd. To Contact The Firm",2017-09-25 18:03:00 +0000,https://finance.yahoo.com/news/deadline-alert-brower-piven-reminds-180300201.html?.tsrc=rss,"The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Dr."
RDY,RDY:US,BBG000NJ96L6,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-09-25 16:05:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-160500701.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 25, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)",2017-09-23 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddys-shareholder-alert-claimsfiler-025000162.html?.tsrc=rss,"NEW ORLEANS , Sept. 22, 2017 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 24, 2017 to file lead plaintiff applications in a securities ..."
RDY,RDY:US,BBG000NJ96L6,DR. REDDY ALERT: Rosen Law Firm Reminds Dr. Reddy’s Laboratories Ltd. Investors of Important Deadline in First Filed Class Action – RDY,2017-09-22 22:00:00 +0000,https://finance.yahoo.com/news/dr-reddy-alert-rosen-law-220000562.html?.tsrc=rss,"NEW YORK, Sept. 22, 2017-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Dr. Reddy’ s Laboratories Ltd. from June 17, 2015 through August 10, 2017, both dates inclusive of the ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories (RDY) Surges: Stock Moves 5.7% Higher,2017-09-22 14:40:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qcfo1_o-yho/dr-reddys-laboratories-rdy-surges-stock-moves-57-higher-cm849542,Dr Reddy s Laboratories Limited RDY was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy&apos;s Laboratories (RDY) Surges: Stock Moves 5.7% Higher,2017-09-22 12:32:12 +0000,https://finance.yahoo.com/news/dr-reddy-apos-laboratories-rdy-123212413.html?.tsrc=rss,"Dr. Reddy&apos;s Laboratories (RDY) was a big mover last session, as the company saw its shares rise nearly 6% on the day amid huge volumes."
RDY,RDY:US,BBG000NJ96L6,"Health Care Sector Update for 09/21/2017: RDY,AKTX,RWLK",2017-09-21 20:37:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r9hJ-X4M0JI/health-care-sector-update-for-09212017-rdyaktxrwlk-cm849278,Top Health Care StocksTop Health Care Stocks JNJ 1 17 JNJ 1 17 PFE 0 06 PFE 0 06 ABT 0 93 ABT 0 93 MRK 0 33 MRK 0 33 AMGN 0 85 AMGN 0 85 Health care stocks were trending slightly lower this afternoon with the NYSE Health Care Index dropping almost 0 3 while shares of health
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Off Day's Lows",2017-09-21 07:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hy6YZ3rw8io/sensex-nifty-end-off-days-lows-20170921-00352,"Sensex, Nifty End Off Day's Lows"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Inch Higher Led By Pharma Stocks",2017-09-21 00:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cuPW1YErvNk/sensex-nifty-inch-higher-led-by-pharma-stocks-20170921-00002,"Sensex, Nifty Inch Higher Led By Pharma Stocks"
RDY,RDY:US,BBG000NJ96L6,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-09-20 21:16:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-khang-khang-211600058.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 20, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm",2017-09-20 21:01:37 +0000,https://finance.yahoo.com/news/dr-reddys-investor-alert-faruqi-210137180.html?.tsrc=rss,"NEW YORK, Sept. 20, 2017-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr. Reddy's Laboratories Limited of the October 24, 2017 deadline to seek the role of lead ..."
RDY,RDY:US,BBG000NJ96L6,"RDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-09-20 15:45:00 +0000,https://finance.yahoo.com/news/rdy-shareholder-alert-law-offices-154500463.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 20, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Marginally Lower Ahead Of Fed Decision",2017-09-20 07:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ywMZzW0ScHY/sensex-nifty-end-marginally-lower-ahead-of-fed-decision-20170920-00308,"Sensex, Nifty End Marginally Lower Ahead Of Fed Decision"
RDY,RDY:US,BBG000NJ96L6,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm,2017-09-19 20:50:00 +0000,https://finance.yahoo.com/news/important-investor-alert-lundin-law-205000701.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 19, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (''Dr. Reddy's'' or the ''Company'') ..."
RDY,RDY:US,BBG000NJ96L6,"INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy's Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY",2017-09-19 16:14:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-161400749.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 19, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy's ..."
RDY,RDY:US,BBG000NJ96L6,"Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 24th Lead Plaintiff Deadline in Securities Class Action Against Dr. Reddy’s Laboratories Limited (RDY)",2017-09-19 15:29:00 +0000,https://finance.yahoo.com/news/scott-scott-attorneys-law-llp-152900057.html?.tsrc=rss,"Scott+Scott, Attorneys at Law, LLP , a national shareholder and consumer rights litigation firm, reminds investors that a securities class action has been filed against Dr. Reddy’s Laboratories Limited (“Dr."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline - October 24, 2017",2017-09-19 14:41:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144100451.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 19, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Dr. Reddy’s Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017",2017-09-18 15:48:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-154800035.html?.tsrc=rss,"The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr. Reddy’s Laboratories Ltd. who purchased shares between June 17, 2015 and August 10, 2017."
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-16 03:20:00 +0000,https://finance.yahoo.com/news/equity-alert-khang-khang-llp-032000115.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 15, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or ..."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)",2017-09-16 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddys-shareholder-alert-former-025000001.html?.tsrc=rss,"NEW ORLEANS , Sept. 15, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC (""KSF"") and KSF partner, the former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have ..."
RDY,RDY:US,BBG000NJ96L6,"RDY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-09-15 17:26:00 +0000,https://finance.yahoo.com/news/rdy-equity-alert-law-offices-172600002.html?.tsrc=rss,The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr.
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Rebound From Early Losses",2017-09-15 06:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8FkRQvmZTK8/sensex-nifty-rebound-from-early-losses-20170915-00195,"Sensex, Nifty Rebound From Early Losses"
RDY,RDY:US,BBG000NJ96L6,Indivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent,2017-09-15 02:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7gUbQ94f5Pc/indivior-unit-files-lawsuits-in-us-to-protect-suboxone-film-patent-20170915-00060,Indivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-14 17:34:00 +0000,https://finance.yahoo.com/news/equity-alert-lundin-law-pc-173400897.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 14, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" or the ..."
RDY,RDY:US,BBG000NJ96L6,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy’s Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017",2017-09-14 16:05:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-160500509.html?.tsrc=rss,"The following statement is being issued by Levi & Korsinsky, LLP:"
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-13 17:57:00 +0000,https://finance.yahoo.com/news/investor-alert-khang-khang-llp-175700749.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 13, 2017 / Khang & Khang LLP (the ""Firm"") announces the filing of a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Dr. Reddy’s Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017",2017-09-13 16:42:00 +0000,https://finance.yahoo.com/news/klein-law-firm-announces-commencement-164200843.html?.tsrc=rss,"The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr. Reddy’s Laboratories Ltd. who purchased shares between June 17, 2015 and August 10, 2017."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline - October 24, 2017",2017-09-13 14:41:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144100875.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 13, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Choppy Session Flat",2017-09-13 07:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVXheNxkeII/sensex-nifty-end-choppy-session-flat-20170913-00311,"Sensex, Nifty End Choppy Session Flat"
RDY,RDY:US,BBG000NJ96L6,Teva's New CEO Brings No Relief: Generic Drugmakers to Dump,2017-09-12 21:37:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HktdhAhOZkw/tevas-new-ceo-brings-no-relief-generic-drugmakers-to-dump-cm844604,Teva Pharmaceutical Industries Limited TEVA on Monday announced that it has hired H Lundbeck s HLUYY chief Kåre Schultz as its new CEO The appointment ended Teva s more than six month long search for a permanent CEO after Erez Vigodman stepped down in February this year Israel based Teva
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-12 19:36:00 +0000,https://finance.yahoo.com/news/shareholder-alert-lundin-law-pc-193600092.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 12, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,Teva&apos;s New CEO Brings No Relief: Generic Drugmakers to Dump,2017-09-12 19:33:07 +0000,https://finance.yahoo.com/news/teva-apos-ceo-brings-no-193307197.html?.tsrc=rss,"The New CEO appointment at Teva (TEVA has once again shifted focus to the Generic Drug industry, which is presently facing several challenges."
RDY,RDY:US,BBG000NJ96L6,"The Klein Law Firm Announces a Class Action Filed on Behalf of Dr. Reddy’s Laboratories Ltd. Shareholders and a Lead Plaintiff Deadline of October 24, 2017 (RDY)",2017-09-12 16:41:21 +0000,https://finance.yahoo.com/news/klein-law-firm-announces-class-164121010.html?.tsrc=rss,"NEW YORK, Sept. 12, 2017-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr. Reddy’ s Laboratories Ltd. who purchased shares between June 17, 2015 ..."
RDY,RDY:US,BBG000NJ96L6,"Aurigene, a Wholly Owned Subsidiary of Dr. Reddy’s, and Curis Announce CA-170 Program Update Following Data Presented at ESMO 2017",2017-09-12 13:22:00 +0000,https://finance.yahoo.com/news/aurigene-wholly-owned-subsidiary-dr-132200911.html?.tsrc=rss,"Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd. and a specialized biotechnology company engaged in discovery and early clinical development of novel and best-in-class therapies to treat cancer and inflammatory diseases, today announced plans to initiate a Phase 2 trial of CA-170, a PDL1-VISTA inhibitor to be conducted at sites in India."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare Conference,2017-09-12 13:11:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-limited-present-131100095.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced that the Company will be present at the Morgan Stanley 15th Annual Global Healthcare Conference on Tuesday, September 12th, 2017, in New York City."
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-11 20:37:00 +0000,https://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-203700592.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 11, 2017 / Khang & Khang LLP (the ''Firm'') announces the filing of a securities class action lawsuit against Dr. Reddy's Laboratories Limited (''Dr. Reddy's'' or the ..."
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Ltd. - RDY,2017-09-11 16:30:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-163000502.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 11, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy’s Laboratories Ltd. (""Dr. Reddy's"" or the ""Company"") (NYSE: ..."
RDY,RDY:US,BBG000NJ96L6,"RDY INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-09-11 16:28:00 +0000,https://finance.yahoo.com/news/rdy-investor-alert-law-offices-162800450.html?.tsrc=rss,The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr.
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-09 03:52:00 +0000,https://finance.yahoo.com/news/investor-alert-lundin-law-pc-035200196.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 8, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Dr. Reddy’s Laboratories Ltd. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit",2017-09-09 03:30:00 +0000,https://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-033000612.html?.tsrc=rss,"The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Dr."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-09-09 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddy-shareholder-alert-claimsfiler-025000046.html?.tsrc=rss,"NEW ORLEANS, Sept. 08, 2017-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 24, 2017 to file lead plaintiff applications in a securities class action ..."
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – RDY,2017-09-08 23:40:53 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-234053610.html?.tsrc=rss,"NEW YORK, Sept. 08, 2017-- Rosen Law Firm, a global investor rights law firm, announces filing of a class action lawsuit on behalf of purchasers of Dr. Reddy’ s Laboratories Ltd. from June 17, 2015 through ..."
RDY,RDY:US,BBG000NJ96L6,"Glancy Prongay & Murray LLP Continues Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors",2017-09-08 23:00:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-continues-230000785.html?.tsrc=rss,"Glancy Prongay & Murray LLP continues its investigation on behalf of investors of Dr. Reddy’s Laboratories, Ltd. concerning the Company’s and its officers’ possible violations of federal securities laws."
RDY,RDY:US,BBG000NJ96L6,"RDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Dr. Reddy’s Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017",2017-09-08 18:29:16 +0000,https://finance.yahoo.com/news/rdy-shareholder-alert-law-offices-182916538.html?.tsrc=rss,"NEW YORK, Sept. 08, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors ..."
RDY,RDY:US,BBG000NJ96L6,Featured Company News - Dr. Reddy's Labs Announces the Launch of Anti-Depressant and Muscle Relaxant Tablets in the US,2017-09-08 11:30:00 +0000,https://finance.yahoo.com/news/featured-company-news-dr-reddys-113000471.html?.tsrc=rss,"Research Desk Line-up: Amphastar Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 8, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ..."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-07 22:11:51 +0000,https://finance.yahoo.com/news/important-equity-alert-khang-khang-221151347.html?.tsrc=rss,"IRVINE, Calif., Sept. 07, 2017-- Khang & Khang LLP announces the filing of a securities class action lawsuit against Dr. Investors who purchased or otherwise acquired shares between June 17, 2015 and August ..."
RDY,RDY:US,BBG000NJ96L6,"INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy’s Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017",2017-09-07 21:05:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-210500286.html?.tsrc=rss,"The following statement is being issued by Levi & Korsinsky, LLP:"
RDY,RDY:US,BBG000NJ96L6,IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-07 16:21:12 +0000,https://finance.yahoo.com/news/important-equity-alert-lundin-law-162112652.html?.tsrc=rss,"LOS ANGELES, Sept. 07, 2017-- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Dr. Reddy’ s Laboratories Limited concerning possible violations of federal ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy’s Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017",2017-09-07 14:40:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144000986.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 7, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-06 21:26:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-212600163.html?.tsrc=rss,"IRVINE, Calif. , Sept. 6, 2017 /PRNewswire/ -- Khang & Khang LLP (the ""Firm"") announces the filing of a securities class action lawsuit against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Bupropion Hydrochloride Extended-Release Tablets, USP (XL) in the U.S. Market",2017-09-06 08:14:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-081400430.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has launched Bupropion Hydrochloride Extended-Release Tablets, USP , 150 mg and 300 mg, a therapeutic equivalent generic version of Wellbutrin XL® Tablets, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Metaxalone Tablets, USP in the U.S. Market",2017-09-06 08:03:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-080300518.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has launched Metaxalone Tablets, USP 800 mg, a therapeutic equivalent generic version of Skelaxin® Tablets, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy’s Laboratories Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 – RDY",2017-09-05 16:34:09 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-163409591.html?.tsrc=rss,"NEW YORK, Sept. 05, 2017-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Dr. Reddy’ s Laboratories Ltd. ..."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-09-05 14:46:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-khang-khang-144600095.html?.tsrc=rss,"Khang & Khang LLP announces the filing of a securities class action lawsuit against Dr. Reddy’s Laboratories Limited . Investors who purchased or otherwise acquired shares between June 17, 2015 and August 10, 2017, inclusive , are encouraged to contact the Firm in advance of the October 24, 2017 lead plaintiff motion deadline."
RDY,RDY:US,BBG000NJ96L6,"Sensex Down 50 Points In Early Trade; Nifty At 9,959",2017-09-04 00:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TuntIbUg7E8/sensex-down-50-points-in-early-trade-nifty-at-9959-20170904-00001,"Sensex Down 50 Points In Early Trade; Nifty At 9,959"
RDY,RDY:US,BBG000NJ96L6,"FORTHCOMING DEADLINES: J&W Announces Class Action Suits against Forterra, Inc., Foundation Medicine, Inc., Teva Pharmaceutical Industries Limited and Dr. Reddys Laboratories Limited; Investors Encouraged to Contact Firm",2017-09-02 17:10:00 +0000,https://finance.yahoo.com/news/forthcoming-deadlines-j-w-announces-171000228.html?.tsrc=rss,"Johnson & Weaver, LLP (J&W) reminds investors that a class action case was filed against Forterra, Inc. (FRTA) (""Forterra"") for purchasers of the stock between October 19, 2016 and May 12, 2017 or traceable to the Company's Initial Public Offering (""IPO"").  The complaint alleges that the Registration Statement used to conduct the IPO contained inaccurate statements and omitted facts necessary to make other statements made therein not misleading."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Dr. Reddy’s Laboratories Limited and Encourages Investors With Losses to Contact the Firm,2017-09-02 03:55:00 +0000,https://finance.yahoo.com/news/important-investor-alert-lundin-law-035500533.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws between June 17, 2015 and August 10, 2017, inclusive ."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)",2017-09-02 02:50:00 +0000,https://finance.yahoo.com/news/dr-reddys-shareholder-alert-former-025000782.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 24, 2017 to file lead plaintiff applications in a securities ..."
RDY,RDY:US,BBG000NJ96L6,RBP Global Holdings Ltd -- Moody's: Patent ruling is credit negative for Indivior,2017-09-01 17:54:09 +0000,http://finance.yahoo.com/r/5ec1960b-8563-3a29-8edb-ba20f30b88de/viewresearchdoc.aspx?docid=PR_372121&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170901_PR_372121&yptr=yahoo&.tsrc=rss,"Announcement: Moody's: Patent ruling is credit negative for Indivior. Global Credit Research- 01 Sep 2017. New York, September 01, 2017-- Moody's Investors Service commented that an unfavorable patent ..."
RDY,RDY:US,BBG000NJ96L6,The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Dr. Reddy’s Laboratories Ltd.,2017-09-01 15:57:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-155700059.html?.tsrc=rss,The Klein Law Firm announces the commencement of an investigation of Dr. Reddy’s Laboratories Ltd. concerning possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,Indivior To Appeal Ruling To Defend Intellectual Property For Suboxone Film,2017-09-01 02:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lU0nFVb5RCw/indivior-to-appeal-ruling-to-defend-intellectual-property-for-suboxone-film-20170901-00061,Indivior To Appeal Ruling To Defend Intellectual Property For Suboxone Film
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Modestly Higher In Early Trade",2017-09-01 00:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z5hPH7k-BXI/sensex-nifty-modestly-higher-in-early-trade-20170901-00004,"Sensex, Nifty Modestly Higher In Early Trade"
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited,2017-08-31 19:58:00 +0000,https://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-195800673.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dr. Reddy’s Laboratories Limited for violations of §§10 and 20 of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S."
RDY,RDY:US,BBG000NJ96L6,Robbins Arroyo LLP: Dr. Reddy's Laboratories Limited (RDY) Misled Shareholders According to a Recently Filed Class Action,2017-08-31 19:34:00 +0000,https://finance.yahoo.com/news/robbins-arroyo-llp-dr-reddys-193400689.html?.tsrc=rss,Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Dr. Reddy's Laboratories Limited . The complaint is brought on behalf of all purchasers of Dr.
RDY,RDY:US,BBG000NJ96L6,The Klein Law Firm Notifies Investors of Commencement of an Investigation Concerning Possible Violations of Federal Securities Laws by Dr. Reddy’s Laboratories Ltd. (RDY),2017-08-31 16:37:00 +0000,https://finance.yahoo.com/news/klein-law-firm-notifies-investors-163700831.html?.tsrc=rss,The Klein Law Firm announces the commencement of an investigation of Dr. Reddy’s Laboratories Ltd. concerning possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,DR. REDDY LOSS NOTICE: Rosen Law Firm Reminds Dr. Reddy’s Laboratories Ltd. Investors of Important Deadline in First Filed Class Action,2017-08-31 16:15:00 +0000,https://finance.yahoo.com/news/dr-reddy-loss-notice-rosen-161500647.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, reminds purchasers of Dr. Reddy’s Laboratories Ltd. from June 17, 2015 through August 10, 2017, both dates inclusive of the important October 24, 2017 lead plaintiff deadline in the first filed class action commenced by the firm."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017",2017-08-31 14:40:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-144000438.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 31, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears",2017-08-31 02:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bBxkaP_xFs8/amgns-endeavor-awaits-verdict-nvs-scripts-history-otic-is-not-music-to-ears-20170831-00080,"AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears"
RDY,RDY:US,BBG000NJ96L6,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-08-30 22:45:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-224500669.html?.tsrc=rss,"Khang & Khang LLP announces the filing of a securities class action lawsuit against Dr. Reddy’s Laboratories Limited . Investors who purchased or otherwise acquired shares between June 17, 2015 and August 10, 2017, inclusive , are encouraged to contact the Firm in advance of the October 24, 2017 lead plaintiff motion deadline."
RDY,RDY:US,BBG000NJ96L6,VIVUS Settles With Dr. Reddy's Labs On Qsymia Patent Litigation,2017-08-30 22:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RgtO9H3DT8E/vivus-settles-with-dr-reddys-labs-on-qsymia-patent-litigation-20170830-01264,VIVUS Settles With Dr. Reddy's Labs On Qsymia Patent Litigation
RDY,RDY:US,BBG000NJ96L6,IMPORTANT DR. REDDY'S LABORATORIES LIMITED INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr. Reddy's Laboratories Limited American Depositary Receipts (ADRs),2017-08-30 21:00:00 +0000,https://finance.yahoo.com/news/important-dr-reddys-laboratories-limited-210000292.html?.tsrc=rss,"NEW YORK, Aug. 30, 2017-- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the District of New Jersey ..."
RDY,RDY:US,BBG000NJ96L6,The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Dr. Reddy’s Laboratories Limited Investors and Encourages Investors to Contact the Firm,2017-08-30 20:12:00 +0000,https://finance.yahoo.com/news/law-offices-howard-g-smith-201200643.html?.tsrc=rss,"Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Dr. Reddy’s Laboratories Limited securities between June 17, 2015 and August 10, 2017, inclusive ."
RDY,RDY:US,BBG000NJ96L6,RDY INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr. Reddy’s Laboratories Ltd.,2017-08-30 19:13:00 +0000,https://finance.yahoo.com/news/rdy-investor-alert-law-offices-191300762.html?.tsrc=rss,The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Dr. Reddy’s Laboratories Ltd. violated federal securities laws.
RDY,RDY:US,BBG000NJ96L6,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-08-30 18:38:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-lundin-law-183800079.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws between June 17, 2015 and August 10, 2017, inclusive ."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) To Contact Brower Piven Before The Lead Plaintiff Deadline",2017-08-29 21:55:47 +0000,https://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-215547582.html?.tsrc=rss,"STEVENSON, Md., Aug. 29, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
RDY,RDY:US,BBG000NJ96L6,RDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr. Reddy’s Laboratories Ltd.,2017-08-29 21:13:00 +0000,https://finance.yahoo.com/news/rdy-shareholder-alert-law-offices-211300188.html?.tsrc=rss,The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Dr. Reddy’s Laboratories Ltd. violated federal securities laws.
RDY,RDY:US,BBG000NJ96L6,"Scott+Scott, Attorneys at Law, LLP Announces Filing of Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)",2017-08-29 15:58:00 +0000,https://finance.yahoo.com/news/scott-scott-attorneys-law-llp-155800606.html?.tsrc=rss,"NEW YORK , Aug. 29, 2017 /PRNewswire/ --  Scott+Scott, Attorneys at Law, LLP (""Scott+Scott""), a national shareholder and consumer rights litigation firm, announces that a securities class action ..."
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Dr. Reddy’s Laboratories Limited,2017-08-28 23:22:00 +0000,https://finance.yahoo.com/news/investor-alert-goldberg-law-pc-232200158.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dr. Reddy’s Laboratories Limited for violations of §§10 and 20 of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm",2017-08-28 20:44:25 +0000,https://finance.yahoo.com/news/dr-reddys-investor-alert-faruqi-204425911.html?.tsrc=rss,"NEW YORK, Aug. 28, 2017-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr. Reddy's Laboratories Limited of the October 24, 2017 deadline to seek the role of lead plaintiff ..."
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Dr. Reddy’s Laboratories Limited Investors,2017-08-28 18:42:00 +0000,https://finance.yahoo.com/news/investor-alert-law-offices-howard-184200605.html?.tsrc=rss,Law Offices of Howard G. Smith continues its investigation on behalf of Dr. Reddy’s Laboratories Limited investors concerning the Company and its officers’ possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr. Reddy’s Laboratories Limited",2017-08-28 16:33:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-163300249.html?.tsrc=rss,Levi & Korsinsky announces it has commenced an investigation of Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017",2017-08-28 14:15:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141500194.html?.tsrc=rss,"NEW YORK , Aug. 28, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dr. Reddy's Laboratories Ltd. (""Dr. ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Laboratories Breathes New Life into Doan’s® in New Marketing Campaign,2017-08-28 12:45:00 +0000,https://finance.yahoo.com/news/dr-reddy-laboratories-breathes-life-124500329.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. has launched a U.S. marketing campaign to reintroduce back pain–reliever Doan’s®, available in caplets and a new 4% lidocaine plus menthol cream formulation ."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Cefixime for Oral Suspension, USP in the U.S. Market",2017-08-28 07:13:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-071300846.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has launched Cefixime for Oral Suspension, USP 100 mg/5mL and 200 mg/5mL, a therapeutic equivalent generic version of Suprax® for Oral Suspension, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Labs Launches Cefixime For Oral Suspension, USP In US",2017-08-28 03:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J2q3BqckjE8/dr-reddys-labs-launches-cefixime-for-oral-suspension-usp-in-us-20170828-00077,"Dr. Reddy's Labs Launches Cefixime For Oral Suspension, USP In US"
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY’S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)",2017-08-27 02:47:38 +0000,https://finance.yahoo.com/news/dr-reddy-shareholder-alert-former-024738055.html?.tsrc=rss,"NEW ORLEANS, Aug. 26, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 25, 2017 to file lead ..."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-08-26 01:28:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-khang-khang-012800062.html?.tsrc=rss,Khang & Khang LLP announces that it is investigating claims against Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd.,2017-08-25 20:45:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-204500890.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Dr. Reddy’s Laboratories Ltd. from June 17, 2015 through August 10, 2017, both dates inclusive ."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. : RDY-US: Dividend Analysis : July 17th, 2017 (record date) : By the numbers : August 24, 2017",2017-08-24 16:38:43 +0000,http://finance.yahoo.com/r/ab15713b-9704-361e-80eb-5918e472dd15/dr-reddys-laboratories-ltd-rdy-us-dividend-analysis-july-17th-2017-record-date-by-the-numbers-august-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Our analysis is based on comparing Dr. Reddy’s Laboratories Ltd. with the following peers – Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Cipla Limited Sponsored GDR RegS, Wockhardt Limited Sponsored GDR, GlaxoSmithKline plc Sponsored ADR, Sanofi Sponsored ADR and Novartis AG Sponsored ADR (PFE-US, TEVA-US, CPLF20-US, WKHZF-US, GSK-US, SNY-US and ... Read more
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,Featured Company News - Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology,2017-08-24 11:40:00 +0000,https://finance.yahoo.com/news/featured-company-news-dr-reddys-114000797.html?.tsrc=rss,"Research Desk Line-up: Taro Pharma Industries Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 24, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Marginally Higher",2017-08-24 07:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4cFRnyjU_0g/sensex-nifty-end-marginally-higher-20170824-00348,"Sensex, Nifty End Marginally Higher"
RDY,RDY:US,BBG000NJ96L6,"INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors",2017-08-23 22:26:00 +0000,https://finance.yahoo.com/news/investor-alert-law-offices-howard-222600653.html?.tsrc=rss,"Law Offices of Howard G. Smith announces an investigation on behalf of Dr. Reddy’s Laboratories, Ltd. investors concerning the Company and its officers’ possible violations of federal securities laws."
RDY,RDY:US,BBG000NJ96L6,"Sensex Up 165 Points In Opening Trade; Nifty Rises Above 9,800",2017-08-23 00:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BrpXRaNW5EY/sensex-up-165-points-in-opening-trade-nifty-rises-above-9800-20170823-00005,"Sensex Up 165 Points In Opening Trade; Nifty Rises Above 9,800"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Range-bound Session Marginally Higher",2017-08-22 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vyGrX-OesKA/sensex-nifty-end-rangebound-session-marginally-higher-20170822-00257,"Sensex, Nifty End Range-bound Session Marginally Higher"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology,2017-08-22 05:50:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-licensing-055000666.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. , through its wholly owned subsidiary Promius Pharma, LLC, announced today that it has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Labs Announces Out-Licensing Of DFD-06 To Encore Dermatology,2017-08-22 01:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DUN6GPbdxSM/dr-reddys-labs-announces-outlicensing-of-dfd06-to-encore-dermatology-20170822-00033,Dr. Reddy's Labs Announces Out-Licensing Of DFD-06 To Encore Dermatology
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Reverse Early Gains To End Lower",2017-08-21 07:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zUU_BajfKrk/sensex-nifty-reverse-early-gains-to-end-lower-20170821-00298,"Sensex, Nifty Reverse Early Gains To End Lower"
RDY,RDY:US,BBG000NJ96L6,"ETFs with exposure to Dr. Reddy’s Laboratories Ltd. : August 16, 2017",2017-08-16 22:31:39 +0000,http://finance.yahoo.com/r/b3437f9b-c378-391c-b70b-78bbf2302ae4/etfs-with-exposure-to-dr-reddys-laboratories-ltd-august-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dr. Reddy’s Laboratories Ltd. Here are 5 ETFs with the largest exposure to RDY-US. Comparing the performance and risk of Dr. Reddy’s Laboratories Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Dr. Reddy’s Laboratories Limited,2017-08-14 21:16:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-lundin-law-211600676.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Alert: J&W Investigates Dr. Reddy's Laboratories Ltd.; Has Your Dr. Reddy's Investment Declined in Value?,2017-08-12 16:01:00 +0000,https://finance.yahoo.com/news/dr-reddys-rdy-alert-j-160100092.html?.tsrc=rss,"SAN DIEGO, Aug. 12, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Dr. Reddy's Laboratories Ltd. (RDY) and certain of its officers.  On November 6, 2015, Dr. Reddy's reported that the Company received a ""warning letter"" from U.S. regulators over inadequate quality controls at three manufacturing plants producing drugs for cancer and other diseases.  The next trading day, on November 9, the Company held an investor conference call to discuss the warning letter.  On the call, it was further revealed that it was not just the three facilities singled out in the warning letter that was experiencing problems.  In fact, the FDA required Dr. Reddy's to implement changes for every manufacturing site the Company operated.  Specifically, Dr. Reddy's disclosed to investors that the FDA found deficiencies in its documentation practices and control, laboratory testing practices, adequacy of standard operating procedures, and incident investigation practices."
RDY,RDY:US,BBG000NJ96L6,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm,2017-08-11 19:58:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-195800070.html?.tsrc=rss,Khang & Khang LLP announces that it is investigating claims against Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,"Glancy Prongay & Murray LLP Commences Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors",2017-08-11 16:39:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-163900283.html?.tsrc=rss,"Glancy Prongay & Murray LLP announces an investigation on behalf of investors of Dr. Reddy’s Laboratories, Ltd. concerning the Company’s and its officers’ possible violations of federal securities laws."
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Dr. Reddy’s Laboratories Limited,2017-08-11 15:47:00 +0000,https://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-154700912.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dr. Reddy’s Laboratories Limited ."
RDY,RDY:US,BBG000NJ96L6,"DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Dr. Reddy's Laboratories Limited To Contact The Firm",2017-08-10 20:13:00 +0000,https://finance.yahoo.com/news/dr-reddys-investor-alert-faruqi-201300071.html?.tsrc=rss,"NEW YORK , Aug. 10, 2017 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Dr. Reddy's Laboratories Limited (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Ltd. (RDY)",2017-08-10 17:21:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-172100058.html?.tsrc=rss,"NEW YORK , Aug. 10, 2017 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr. Reddy’s Laboratories Limited",2017-08-10 17:18:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-171800957.html?.tsrc=rss,Levi & Korsinsky announces it has commenced an investigation of Dr. Reddy’s Laboratories Limited concerning possible violations of federal securities laws.
RDY,RDY:US,BBG000NJ96L6,EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dr. Reddy’s Laboratories Ltd. – RDY,2017-08-10 16:29:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-162900467.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Dr. Reddy’s Laboratories Ltd. resulting from allegations that Dr."
RDY,RDY:US,BBG000NJ96L6,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Ltd. - RDY,2017-08-10 15:10:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-151000274.html?.tsrc=rss,"NEW YORK , Aug. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Ltd. (""Dr. Reddy's"" or the ""Company"") (NYSE:  RDY).   ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Hit One-month Lows",2017-08-10 07:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WVoYGtCIzjA/sensex-nifty-hit-onemonth-lows-20170810-00416,"Sensex, Nifty Hit One-month Lows"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Tumble After Sebi Crackdown On Shell Companies",2017-08-08 07:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7qRH-s8dw-4/sensex-nifty-tumble-after-sebi-crackdown-on-shell-companies-20170808-00493,"Sensex, Nifty Tumble After Sebi Crackdown On Shell Companies"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Range-bound Session Lower",2017-08-07 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BkdB3NrqG9Q/sensex-nifty-end-rangebound-session-lower-20170807-00325,"Sensex, Nifty End Range-bound Session Lower"
RDY,RDY:US,BBG000NJ96L6,"Sensex Ends 87 Points Points Higher After Late Surge; Nifty At 10,066",2017-08-04 07:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0z6PTRODDcY/sensex-ends-87-points-points-higher-after-late-surge-nifty-at-10066-20170804-00329,"Sensex Ends 87 Points Points Higher After Late Surge; Nifty At 10,066"
RDY,RDY:US,BBG000NJ96L6,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Hits 13-Year Low,2017-08-03 23:01:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sFy_A5oXNGQ/teva-pharmaceutical-industries-ltd-adr-teva-stock-hits-13-year-low-cm826954,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s no denying that today s earnings report is not good news for Israel based Teva Pharmaceutical Industries Ltd ADR NYSE TEVA the world s largest generic drug maker and the largest company in
RDY,RDY:US,BBG000NJ96L6,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Hits 13-Year Low,2017-08-03 18:00:36 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-180036878.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q1, 2018 By the Numbers : August 2, 2017",2017-08-02 17:58:37 +0000,http://finance.yahoo.com/r/24a1792e-469e-340a-a455-ee4307ae2ee4/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-q1-2018-by-the-numbers-august-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Dr. Reddy’s Laboratories Ltd. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Dr. Reddy’s Laboratories Ltd. – GlaxoSmithKline plc Sponsored ADR and Novartis AG Sponsored ADR (GSK-US and NVS-US) that have also reported for this period. Highlights Summary numbers: ... Read more
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Lower After RBI Policy Review",2017-08-02 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QrP6yHctdFg/sensex-nifty-end-lower-after-rbi-policy-review-20170802-00493,"Sensex, Nifty End Lower After RBI Policy Review"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Fluctuate Ahead Of RBI Policy Decision",2017-08-02 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ogBMthpVrNU/sensex-nifty-fluctuate-ahead-of-rbi-policy-decision-20170802-00005,"Sensex, Nifty Fluctuate Ahead Of RBI Policy Decision"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's (RDY) Earnings Decline Y/Y in Q1, Sales Rise",2017-07-31 16:57:20 +0000,,Dr Reddy s Laboratories Ltd RDY reported first quarter fiscal 2018 earnings per American Depositary Share ADS of 6 cents down from 12 cents in the year ago quarter Revenues increased 2 4 year over year to 513 million Notably the company s share price declined 18 8 year to
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's (RDY) Earnings Decline Y/Y in Q1, Sales Rise",2017-07-31 16:57:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yQRyrwVVp8E/dr-reddys-rdy-earnings-decline-yy-in-q1-sales-rise-cm824338,Dr Reddy s Laboratories Ltd RDY reported first quarter fiscal 2018 earnings per American Depositary Share ADS of 6 cents down from 12 cents in the year ago quarter Revenues increased 2 4 year over year to 513 million Notably the company s share price declined 18 8 year to
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy&apos;s (RDY) Earnings Decline Y/Y in Q1, Sales Rise",2017-07-31 14:44:02 +0000,https://finance.yahoo.com/news/dr-reddy-apos-rdy-earnings-144402500.html?.tsrc=rss,Dr. Reddy&apos;s Laboratories Ltd.&apos;s (RDY) first-quarter fiscal 2018 earnings per American Depositary Share (ADS) declined year over year while sales increased from the year ago quarter.
RDY,RDY:US,BBG000NJ96L6,"Sensex Rises 205 Points; Nifty Ends At 10,077",2017-07-31 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VGQCkZk29PY/sensex-rises-205-points-nifty-ends-at-10077-20170731-00426,"Sensex Rises 205 Points; Nifty Ends At 10,077"
RDY,RDY:US,BBG000NJ96L6,Stocks That Fell to 3-Year Lows in the Week of July 28,2017-07-30 22:53:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Dbb9VJVJck/stocks-that-fell-to-3-year-lows-in-the-week-of-july-28-cm823949,Macerich Co MAC Dr Reddy s Laboratories Ltd RDY Foot Locker Inc FL and Seneca Foods Corp SENEB have declined to their three year lows Macerich Co MAC Dr Reddy s Laboratories Ltd RDY Foot Locker Inc FL and Seneca Foods Corp SENEB have declined to
RDY,RDY:US,BBG000NJ96L6,Doctor Reddy's posts 1Q profit,2017-07-28 23:40:19 +0000,https://finance.yahoo.com/news/doctor-reddys-posts-1q-profit-133945083.html?.tsrc=rss,"On a per-share basis, the Hyderabad, India-based company said it had net income of 6 cents. The pharmaceutical posted revenue of $513 million in the period. Doctor Reddy's shares have dropped 15 percent ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Becomes Oversold,2017-07-28 17:59:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mFCSPT_BGL0/dr-reddys-laboratories-becomes-oversold-cm823472,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s and CHD Bioscience Announce Global License and Commercialization Agreement for Phase III Clinical Trial Candidate for Mitigation of Surgical Site Infections,2017-07-27 12:47:00 +0000,https://finance.yahoo.com/news/dr-reddy-chd-bioscience-announce-124700898.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. and CHD Bioscience Inc., a privately-held biopharmaceutical company, today announced a global licensing agreement for the clinical development and commercialization of Dr."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q1 FY18 Financial Results,2017-07-27 12:23:00 +0000,https://finance.yahoo.com/news/dr-reddy-q1-fy18-financial-122300649.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the first quarter ended June 30, 2017 under International Financial Reporting Standards ."
RDY,RDY:US,BBG000NJ96L6,Investor Network: Dr. Reddy's Laboratories Ltd. to Host Earnings Call,2017-07-27 11:30:00 +0000,https://finance.yahoo.com/news/investor-network-dr-reddys-laboratories-113000638.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Dr. Reddy's Laboratories Ltd. (NYSE: RDY ) will be discussing their earnings results in their Q1 Earnings Call to be held on Thursday, July 27, 2017 at 9:00 ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Flat Amid F&O Expiry",2017-07-27 07:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AVUGUV-lP-g/sensex-nifty-end-flat-amid-fo-expiry-20170727-00816,"Sensex, Nifty End Flat Amid F&O Expiry"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Up On Global Cues",2017-07-26 22:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/36gasdcUFIU/sensex-nifty-seen-up-on-global-cues-20170726-02023,"Sensex, Nifty Seen Up On Global Cues"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Flat On Muted Global Cues",2017-07-23 22:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E67fk5XX3eg/sensex-nifty-seen-flat-on-muted-global-cues-20170723-00080,"Sensex, Nifty Seen Flat On Muted Global Cues"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's to Release Q1 FY18 Results on July 27, 2017",2017-07-14 14:51:00 +0000,https://finance.yahoo.com/news/dr-reddys-release-q1-fy18-145100832.html?.tsrc=rss,"Dr. Reddy's Laboratories will announce results for the First Quarter ended June 30, 2017 on Thursday, July 27, 2017 after the Board Meeting."
RDY,RDY:US,BBG000NJ96L6,"ETFs with exposure to Dr. Reddy’s Laboratories Ltd. : July 12, 2017",2017-07-12 18:55:41 +0000,http://finance.yahoo.com/r/5aae2574-e639-39f1-aeb7-0d645d2801ca/etfs-with-exposure-to-dr-reddys-laboratories-ltd-july-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dr. Reddy’s Laboratories Ltd. Here are 5 ETFs with the largest exposure to RDY-US. Comparing the performance and risk of Dr. Reddy’s Laboratories Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Marginally Lower On Global Cues",2017-07-07 07:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6OvlqsDzt0/sensex-nifty-end-marginally-lower-on-global-cues-20170707-00225,"Sensex, Nifty End Marginally Lower On Global Cues"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Modestly Lower On Weak Global Cues",2017-07-07 00:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ScgC_G1u2Uk/sensex-nifty-modestly-lower-on-weak-global-cues-20170707-00004,"Sensex, Nifty Modestly Lower On Weak Global Cues"
RDY,RDY:US,BBG000NJ96L6,VIVUS Settles with Teva on Weight Management Drug Generic,2017-07-06 15:45:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lOu-XycPBV4/vivus-settles-with-teva-on-weight-management-drug-generic-cm812369,VIVUS Inc VVUS announced that it has entered into a settlement agreement with Actavis Laboratories a subsidiary of generic company Teva Pharmaceutical Industries Limited TEVA thereby resolving a three year old patent litigation related to its weight management drug Qsymia Shares of
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F,2017-07-06 01:59:00 +0000,https://finance.yahoo.com/news/dr-reddy-laboratories-limited-announces-015900931.html?.tsrc=rss,"Dr. Reddy’s Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2017 was filed with the United States Securities and Exchange Commission on June 19, 2017."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Finish Choppy Session On Flat Note",2017-07-04 07:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_P5xPWS9xU/sensex-nifty-finish-choppy-session-on-flat-note-20170704-00179,"Sensex, Nifty Finish Choppy Session On Flat Note"
RDY,RDY:US,BBG000NJ96L6,"Pricing, Competition Remain Headwinds for Pharma in 2017",2017-06-29 23:03:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2bAOJobSSZc/pricing-competition-remain-headwinds-for-pharma-in-2017-cm810281,Although fears regarding the drug pricing issue have waned it will nevertheless remain a headwind until the Trump administration comes out with a policy for controlling drug prices Drug pricing is an issue that weighed on pharma and biotech stocks for more than a year The sector
RDY,RDY:US,BBG000NJ96L6,"ETFs with exposure to Dr. Reddy’s Laboratories Ltd. : June 27, 2017",2017-06-27 19:37:13 +0000,http://finance.yahoo.com/r/287c68f8-b41c-3d27-83ad-c9f275da43b1/etfs-with-exposure-to-dr-reddys-laboratories-ltd-june-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dr. Reddy’s Laboratories Ltd. Here are 5 ETFs with the largest exposure to RDY-US. Comparing the performance and risk of Dr. Reddy’s Laboratories Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,"Health Care Sector Update for 06/27/2017: JNJ, PFE, ABT, MRK, AMGN, ARLZ, ESPR, SNY",2017-06-27 13:09:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JNNQzK44kI8/health-care-sector-update-for-06272017-jnj-pfe-abt-mrk-amgn-arlz-espr-sny-cm808497,Top Health Care stocks Top Health Care stocks JNJ 0 4 JNJ 0 4 PFE flatPFE flat ABT flatABT flat MRK 1 MRK 1 AMGN flatAMGN flat Health care shares were mainly inactive in pre market trade Tuesday Health care shares were mainly inactive in pre market trade Tuesday In health
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017",2017-06-26 13:58:18 +0000,http://finance.yahoo.com/r/364df5bc-ad08-309d-a0f2-2c5deb5ae53e/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-q4-2017-by-the-numbers-june-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Dr. Reddy’s Laboratories Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Dr. Reddy’s Laboratories Ltd. – Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Cipla Limited Sponsored GDR 144A, GlaxoSmithKline plc Sponsored ADR, Novartis AG Sponsored ADR and ... Read more
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,InPlay from Briefing.com,2017-06-19 15:52:43 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
RDY,RDY:US,BBG000NJ96L6,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Time to Go Contrarian?,2017-06-19 15:52:13 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-155213099.html?.tsrc=rss,"The pharmaceutical business is a love-hate affair.  Right now, Wall Street is feeling the latter for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Although the Israeli pharma is one of the most respected names in the industry, TEVA stock plays the opposite role."
RDY,RDY:US,BBG000NJ96L6,"Sensex Drops 80 Points On Global Cues; Nifty Ends Below 9,600",2017-06-15 07:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o3tVNdJWd2E/sensex-drops-80-points-on-global-cues-nifty-ends-below-9600-20170615-00331,"Sensex Drops 80 Points On Global Cues; Nifty Ends Below 9,600"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Fluctuate In Early Trade",2017-06-14 00:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TWWgqfWt9MI/sensex-nifty-fluctuate-in-early-trade-20170614-00006,"Sensex, Nifty Fluctuate In Early Trade"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Drift Lower In Cautious Trade",2017-06-08 07:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l-w4xaWcqno/sensex-nifty-drift-lower-in-cautious-trade-20170608-00301,"Sensex, Nifty Drift Lower In Cautious Trade"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Drift Lower Despite Firm Asian Cues",2017-06-08 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Ny8CV9nd-o/sensex-nifty-drift-lower-despite-firm-asian-cues-20170608-00011,"Sensex, Nifty Drift Lower Despite Firm Asian Cues"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Bivalirudin for Injection in the U.S. Market,2017-06-06 07:49:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-074900188.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic equivalent generic version of Angiomax® for Injection, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S.,2017-06-06 04:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yx6xUAHPXK4/dr-reddys-launches-angiomax-generic-bivalirudin-for-injection-in-us-20170606-00107,Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S.
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Limited to Present at the Jefferies 2017 Global Healthcare Conference,2017-06-05 16:55:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-limited-present-165500430.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd announced that the Company will be presenting at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6th, 2017, in New York City."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Enters Oversold Territory (RDY),2017-05-26 17:32:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EGlhJRa5UyI/dr-reddys-laboratories-enters-oversold-territory-rdy-cm795409,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
RDY,RDY:US,BBG000NJ96L6,Xgeva Is Expected to See Robust Revenue Performance in 2017,2017-05-24 11:37:03 +0000,http://finance.yahoo.com/r/7305863e-71f4-38c2-8b9f-d71cd5e419b9/xgeva-is-expected-to-see-robust-revenue-performance-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Amgen’s (AMGN) Xgeva was launched commercially in 2010 and is marketed primarily in the US and Europe. The drug crossed the $1 billion annual revenue mark in 2013.
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Modestly Lower",2017-05-24 06:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xsl99fUBFWY/sensex-nifty-end-modestly-lower-20170524-00279,"Sensex, Nifty End Modestly Lower"
RDY,RDY:US,BBG000NJ96L6,Elite Pharmaceuticals Acquires Trimipramine ANDA,2017-05-22 20:11:48 +0000,https://finance.yahoo.com/news/elite-pharmaceuticals-acquires-trimipramine-anda-201148900.html?.tsrc=rss,"NORTHVALE, N.J., May 22, 2017-- Elite Pharmaceuticals, Inc., today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application for Trimipramine Maleate Capsules 25, ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Tumble Amid Global Selloff",2017-05-18 07:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kpzaaa40_S4/sensex-nifty-tumble-amid-global-selloff-20170518-00408,"Sensex, Nifty Tumble Amid Global Selloff"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces USFDA Approval for the Launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market,2017-05-17 08:53:00 +0000,https://finance.yahoo.com/news/dr-reddys-laboratories-announces-usfda-085300447.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has received approval from the U.S. Food and Drug Administration to launch Doxorubicin Hydrochloride Liposome Injection, a therapeutic equivalent generic version of Doxil® , for intravenous use, in the United States market."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's To Launch Generic Version Of Doxil - Quick Facts,2017-05-17 05:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0uHeaIuV7Ns/dr-reddys-to-launch-generic-version-of-doxil--quick-facts-20170517-00158,Dr. Reddy's To Launch Generic Version Of Doxil - Quick Facts
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q4,2017-05-15 17:15:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OozPcvb7nr4/dr-reddys-rdy-earnings-revenues-decline-yy-in-q4-cm789341,Dr Reddy s Laboratories Ltd RDY reported fourth quarter fiscal 2017 earnings per American Depositary Share ADS of 29 cents down from 7 cents in the year ago quarter Revenues declined 5 4 year over year to 548 million Dr Reddy s share price was down 10 9 year to date while the
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy&apos;s (RDY) Earnings & Revenues Decline Y/Y in Q4,2017-05-15 14:56:02 +0000,https://finance.yahoo.com/news/dr-reddy-apos-rdy-earnings-145602427.html?.tsrc=rss,"Dr. Reddy&apos;s Laboratories Ltd. (RDY) reported fourth-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 29 cents, down from 7 cents in the year-ago quarter."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Hit Record Closing Highs",2017-05-15 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EQEPa5Vn6E8/sensex-nifty-hit-record-closing-highs-20170515-00345,"Sensex, Nifty Hit Record Closing Highs"
RDY,RDY:US,BBG000NJ96L6,Doctor Reddy's posts 4Q profit,2017-05-12 14:18:24 +0000,http://finance.yahoo.com/news/doctor-reddys-posts-4q-profit-141824716.html?.tsrc=rss,"On a per-share basis, the Hyderabad, India-based company said it had net income of 29 cents. The pharmaceutical posted revenue of $548 million in the period. For the year, the company reported profit of ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q4 and FY17 Financial Results,2017-05-12 13:51:00 +0000,http://finance.yahoo.com/news/dr-reddy-q4-fy17-financial-135100408.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2017 under International Financial Reporting Standards ."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Opening Flat Ahead Of IIP Data",2017-05-11 22:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_YqdJxclksk/sensex-nifty-seen-opening-flat-ahead-of-iip-data-20170511-01787,"Sensex, Nifty Seen Opening Flat Ahead Of IIP Data"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Up As Macron Wins French Presidency",2017-05-07 22:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6WDk-sCB-cM/sensex-nifty-seen-up-as-macron-wins-french-presidency-20170507-00096,"Sensex, Nifty Seen Up As Macron Wins French Presidency"
RDY,RDY:US,BBG000NJ96L6,"BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up",2017-05-05 15:25:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4E0_JPbrJP8/biomarin-bmrn-posts-earnings-in-q1-sales-top-stock-up-cm784989,BioMarin Pharmaceutical Inc BMRN reported earnings of 3 cents per share in the first quarter of 2017 including stock based compensation expense significantly better than the year ago loss of 36 cents and the Zacks Consensus Estimate of a loss of 30 cents per share Higher gross margins
RDY,RDY:US,BBG000NJ96L6,Agios and Aurigene Enter into Exclusive License Agreement for Novel Small Molecules for Cancer Metabolism Target,2017-04-27 11:30:00 +0000,http://finance.yahoo.com/news/agios-aurigene-enter-exclusive-license-113000140.html?.tsrc=rss,"CAMBRIDGE, Mass., April 27, 2017-- Agios Pharmaceuticals, Inc. and Aurigene Discovery Technologies Limited today announced a global license agreement to research, develop and commercialize small molecule ..."
RDY,RDY:US,BBG000NJ96L6,InPlay from Briefing.com,2017-04-27 07:53:40 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market,2017-04-27 05:28:00 +0000,http://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-052800271.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced today that it has launched Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg, a therapeutic equivalent generic version of Vytorin® Tablets, in the United States market, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Progesterone Capsules in the U.S. Market,2017-04-21 15:40:00 +0000,http://finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-154000686.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd announced today that it has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium® Capsules in the United States market, approved by the U.S."
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for April 20th,2017-04-20 14:06:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BD96cHgiSew/new-strong-sell-stocks-for-april-20th-cm776299,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Dillard s Inc DDS is a major fashion apparel and home furnishings retailer The Zacks Consensus Estimate for its current year earnings has been revised 0 6 downward over the last 30 days Dr Reddy s
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for April 20th,2017-04-20 12:10:12 +0000,http://finance.yahoo.com/news/strong-sell-stocks-april-20th-121012819.html?.tsrc=rss,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
RDY,RDY:US,BBG000NJ96L6,Mylan Down on FDA Warning Letter to Manufacturing Facility,2017-04-12 22:54:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hH0C-TAaIj8/mylan-down-on-fda-warning-letter-to-manufacturing-facility-cm773518,Shares of Mylan Inc MYL declined 2 after the company received a warning letter from the FDA for its manufacturing facility in India The FDA cited significant violations of current good manufacturing practice CGMP regulations for finished pharmaceuticals in the warning letter
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for April 11th,2017-04-11 15:57:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EWILOXwTmFM/new-strong-sell-stocks-for-april-11th-cm772670,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Accelerize Inc ACLZ is a software solution provider for businesses to enhance their digital advertising spends in the U S and worldwide The Zacks Consensus Estimate for its current year earnings has been revised
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for April 11th,2017-04-11 14:14:02 +0000,http://finance.yahoo.com/news/strong-sell-stocks-april-11th-141402634.html?.tsrc=rss,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
RDY,RDY:US,BBG000NJ96L6,Sensex Drops Over 200 Points On Geopolitical Worries; Nifty Dips Below 9200,2017-04-07 06:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XHy7KgX1rcY/sensex-drops-over-200-points-on-geopolitical-worries-nifty-dips-below-9200-20170407-00210,Sensex Drops Over 200 Points On Geopolitical Worries; Nifty Dips Below 9200
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for April 5th,2017-04-05 15:28:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qnhs2lmPemI/new-strong-sell-stocks-for-april-5th-cm770136,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Agnico Eagle Mines Limited AEM involves in the exploration and production of mineral properties in Canada Mexico and Finland The Zacks Consensus Estimate for its current year earnings has been revised 6 2 downward
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for April 5th,2017-04-05 12:58:12 +0000,http://finance.yahoo.com/news/strong-sell-stocks-april-5th-125812838.html?.tsrc=rss,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
RDY,RDY:US,BBG000NJ96L6,India's Dr Reddy's says U.S. FDA raises fresh concerns at Srikakulam drug plant,2017-04-04 15:04:56 +0000,http://finance.yahoo.com/news/indias-dr-reddys-says-u-150456406.html?.tsrc=rss,"India's Dr Reddy's Laboratories  Ltd said on Tuesday that the U.S. Food and Drug  Administration has outlined two more concerns with the company's  Srikakulam drug-making plant after an inspection of the  facility.  Dr Reddy's, which derives a majority of its sales from the  United States, said in statement that it had received an  inspection letter known as 'form 483' from the FDA about the  Srikakulam plant and was addressing the concerns.  It did not say what the FDA observations were, and the FDA  typically does not make such letters public."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration in India,2017-03-27 09:04:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-integra-lifesciences-enter-090400291.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration in India,2017-03-27 09:04:00 +0000,http://finance.yahoo.com/news/dr-reddy-integra-lifesciences-enter-090400148.html?.tsrc=rss,"Dr. Reddy's Laboratories Limited and Integra LifeSciences Holdings Corporation , a leading global medical technology company, announced today that they have entered into an exclusive distribution agreement."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's To Market Integra's DuraGen Product Line In India - Quick Facts,2017-03-27 05:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rnvwZ_E1tno/dr-reddys-to-market-integras-duragen-product-line-in-india--quick-facts-20170327-00146,Dr. Reddy's To Market Integra's DuraGen Product Line In India - Quick Facts
RDY,RDY:US,BBG000NJ96L6,Stocks Reach Their 3-Year Lows,2017-03-26 14:58:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mqbjKzyF10M/stocks-reach-their-3-year-lows-cm765664,Dr Reddy s Laboratories Ltd RDY Rite Aid Corp RAD World Fuel Services Corp INT and Target Corp TGT have reached their three year lows Dr Reddy s Laboratories Ltd RDY Rite Aid Corp RAD World Fuel Services Corp INT and Target Corp TGT have
RDY,RDY:US,BBG000NJ96L6,Stocks Reach Their 3-Year Lows,2017-03-25 19:15:23 +0000,http://finance.yahoo.com/news/stocks-reach-3-lows-191523536.html,Stocks Reach Their 3-Year Lows
RDY,RDY:US,BBG000NJ96L6,Stocks Reach Their 3-Year Lows,2017-03-25 19:15:23 +0000,http://finance.yahoo.com/news/stocks-reach-3-lows-191523536.html?.tsrc=rss,"Dr. Reddy's Laboratories Ltd., Rite Aid Corp., World Fuel Services Corp. and Target Corp have reached their respective three-year lows"
RDY,RDY:US,BBG000NJ96L6,"U.S. bans Indian drugmaker Divi's factory, shares hit 3-year low",2017-03-22 13:20:13 +0000,http://in.finance.yahoo.com/news/u-bans-divis-factory-shares-114156283.html,"U.S. bans Indian drugmaker Divi's factory, shares hit 3-year low"
RDY,RDY:US,BBG000NJ96L6,Sensex Tumbles 318 Points; Nifty Down 91 Points,2017-03-22 08:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nesVVpZJDG4/sensex-tumbles-318-points-nifty-down-91-points-20170322-00377,Sensex Tumbles 318 Points; Nifty Down 91 Points
RDY,RDY:US,BBG000NJ96L6,Asian ADRs Edge Lower as Financial Stocks Head South,2017-03-21 15:46:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gsMAplcW3c8/asian-adrs-edge-lower-as-financial-stocks-head-south-cm763532,American depository receipts of Asian stocks were 0 5 lower at 154 62 on the Bank of New York Mellon Asia ADR Index on Tuesday morning American depository receipts of Asian stocks were 0 5 lower at 154 62 on the Bank of New York Mellon Asia ADR Index on Tuesday morning Decliners in north
RDY,RDY:US,BBG000NJ96L6,CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories,2017-03-16 11:00:00 +0000,http://finance.yahoo.com/news/cytosorbents-announces-cytosorb-partnership-dr-110000580.html?.tsrc=rss,"MONMOUTH JUNCTION, N.J., March 16, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), manufacturer of the CytoSorb® extracorporeal blood purification therapy that reduces excessive levels of inflammatory mediators in critically-ill and cardiac surgery patients, announced today that they have entered into a partnership with Dr. Reddy's Laboratories Ltd for the South African market.  Under the terms of the agreement, Dr. Reddy's has the exclusive rights to distribute CytoSorb for intensive care, cardiac surgery, and other hospital applications in South Africa."
RDY,RDY:US,BBG000NJ96L6,CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories,2017-03-16 11:00:00 +0000,http://finance.yahoo.com/news/cytosorbents-announces-cytosorb-partnership-dr-110000580.html,"[PR Newswire] - MONMOUTH JUNCTION, N.J., March 16, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), manufacturer of the CytoSorb® extracorporeal blood purification therapy that reduces excessive levels of inflammatory mediators in critically-ill and cardiac surgery patients, announced today that they have entered into a partnership with Dr. Reddy's Laboratories Ltd for the South African market. Under the terms of the agreement, Dr. Reddy's has the exclusive rights to distribute CytoSorb for intensive care, cardiac surgery, and other hospital applications in South Africa."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories is Now Oversold (RDY),2017-03-09 20:14:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zzUZyBoAtm8/dr-reddys-laboratories-is-now-oversold-rdy-cm758753,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
RDY,RDY:US,BBG000NJ96L6,"Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed",2017-03-09 18:13:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VtLWdzEo7zI/sucampo-scmp-beats-q4-earnings-2017-view-reaffirmed-cm758652,Sucampo Pharmaceuticals Inc SCMP reported adjusted earnings of 68 cents per share in the fourth quarter of 2016 beating the Zacks Consensus Estimate of 49 cents by 38 8 Reported earnings were also up by 58 1 from the year ago figure of 48 cents Total revenue came in at 73 million up
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Snap Two-day Losing Streak",2017-03-09 05:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kK8kpSDLWmk/sensex-nifty-snap-twoday-losing-streak-20170309-00210,"Sensex, Nifty Snap Two-day Losing Streak"
RDY,RDY:US,BBG000NJ96L6,Sensex Down 42 Points Ahead Of Exit Polls; Nifty Slips 8 Points,2017-03-08 23:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QhxGBkSTMvs/sensex-down-42-points-ahead-of-exit-polls-nifty-slips-8-points-20170308-01456,Sensex Down 42 Points Ahead Of Exit Polls; Nifty Slips 8 Points
RDY,RDY:US,BBG000NJ96L6,Sensex Sheds 145 Points; Nifty Dips Below 8900,2017-03-02 06:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t2h_F18qm_Y/sensex-sheds-145-points-nifty-dips-below-8900-20170302-00372,Sensex Sheds 145 Points; Nifty Dips Below 8900
RDY,RDY:US,BBG000NJ96L6,"Sensex Soars 241 Points; Nifty Closes At 8,945",2017-03-01 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gw8SQ80Jc4o/sensex-soars-241-points-nifty-closes-at-8945-20170301-00372,"Sensex Soars 241 Points; Nifty Closes At 8,945"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Extend Gains; Reliance Industries Shares Soar 6%",2017-02-21 23:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XmLLafPjSeg/sensex-nifty-extend-gains-reliance-industries-shares-soar-6-20170221-01974,"Sensex, Nifty Extend Gains; Reliance Industries Shares Soar 6%"
RDY,RDY:US,BBG000NJ96L6,Sensex Rises 160 Points In Early Trade; Nifty Climbs Above 8800,2017-02-16 23:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_bz2ePXGqPQ/sensex-rises-160-points-in-early-trade-nifty-climbs-above-8800-20170216-01878,Sensex Rises 160 Points In Early Trade; Nifty Climbs Above 8800
RDY,RDY:US,BBG000NJ96L6,7:32 am Dr. Reddy's announces Court patent ruling,2017-02-16 12:32:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#rdy,7:32 am Dr. Reddy's announces Court patent ruling
RDY,RDY:US,BBG000NJ96L6,"The Zacks Analyst Blog Highlights: Dow Chemical, Shell, HSBC Holdings, Exxon Mobil and Dr. Reddy's",2017-02-10 16:20:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hCD_aTY6M4I/the-zacks-analyst-blog-highlights-dow-chemical-shell-hsbc-holdings-exxon-mobil-and-dr-reddys-cm746240,For Immediate Release Chicago IL February 10 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
RDY,RDY:US,BBG000NJ96L6,"The Zacks Analyst Blog Highlights: Dow Chemical, Shell, HSBC Holdings, Exxon Mobil and Dr. Reddy's",2017-02-10 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-dow-143002544.html,"The Zacks Analyst Blog Highlights: Dow Chemical, Shell, HSBC Holdings, Exxon Mobil and Dr. Reddy's"
RDY,RDY:US,BBG000NJ96L6,"Fewer Beats, But Q4 Growth is Highest in 2 Years",2017-02-09 21:17:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iKyv2iqlh9A/fewer-beats-but-q4-growth-is-highest-in-2-years-cm745840,Thursday February 9 2017 The Zacks Research Daily features the best research output of our analyst team In today s write up we are featuring analyst reports on 16 major stocks including reports on Dow Chemical DOW Shell RDS A and HSBC Holdings HSBC These reports have been hand
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Expands Commercial Operations in Europe,2017-02-08 13:22:00 +0000,http://finance.yahoo.com/news/dr-reddys-expands-commercial-operations-132200875.html?.tsrc=rss,"BASEL, Switzerland, February 8, 2017 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd  announced today the expansion of its commercial operations in Europe with the introduction of its portfolio of generics ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Expands Commercial Operations in Europe,2017-02-08 13:22:00 +0000,http://finance.yahoo.com/news/dr-reddys-expands-commercial-operations-132200875.html,"[PR Newswire] - BASEL, Switzerland, February 8, 2017 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd announced today the expansion of its commercial operations in Europe with the introduction of its portfolio of generics ..."
RDY,RDY:US,BBG000NJ96L6,Sensex Drops 45 Points As Rate Cut Hopes Fade; Nifty Ends Flat,2017-02-08 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TzKmXJkhXyI/sensex-drops-45-points-as-rate-cut-hopes-fade-nifty-ends-flat-20170208-00336,Sensex Drops 45 Points As Rate Cut Hopes Fade; Nifty Ends Flat
RDY,RDY:US,BBG000NJ96L6,BioMarin sues to stop generic version of its $90K-a-year drug,2017-02-07 18:24:13 +0000,http://www.bizjournals.com/sanfrancisco/news/2017/02/06/biomarin-bmrn-dr-reddys-laboratories-rdy-kuvan-pku.html?ana=yahoo,BioMarin sues to stop generic version of its $90K-a-year drug
RDY,RDY:US,BBG000NJ96L6,BioMarin sues to stop generic version of its $90K-a-year drug,2017-02-07 18:24:13 +0000,http://finance.yahoo.com/r/477fbbf9-05bc-3829-b9c0-7cc7ae6116ee/biomarin-bmrn-dr-reddys-laboratories-rdy-kuvan-pku.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Rare-disease drug developer BioMarin Pharmaceutical Inc. sued an Indian drug maker that plans to make and sell a version of one of BioMarin's top-selling drugs.  The San Rafael company (BMRN), led by CEO Jean-Jacques Bienaimé, said in a filing Monday in U.S. District Court in New Jersey that a version of the drug Kuvan by Dr. Reddy's Laboratories Ltd. infringes on six BioMarin patents.  The Indian company late last year asked the Food and Drug Administration to approve its powder version of Kuvan, saying that BioMarin's patents are invalid, unenforceable or will not be infringed by manufacturing, use or sale."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7, 2017",2017-02-07 14:44:31 +0000,http://finance.yahoo.com/r/32d410fa-5ccb-38c2-9e5e-e8168bf66208/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-q3-2017-by-the-numbers-february-7-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Dr. Reddy’s Laboratories Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Dr. Reddy’s Laboratories Ltd. – Pfizer Inc., Novartis AG Sponsored ADR and Wockhardt Limited Sponsored GDR (PFE-US, NVS-US and WKHZF-US) that have also reported for this period. ... Read more    
<b>(Read more...)</b>"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7, 2017",2017-02-07 14:44:31 +0000,http://www.capitalcube.com/blog/index.php/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-q3-2017-by-the-numbers-february-7-2017/,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7, 2017"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3,2017-02-06 16:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xqlni1yVH7s/dr-reddys-rdy-earnings-revenues-decline-yy-in-q3-cm743571,Dr Reddy s Laboratories Ltd RDY reported third quarter fiscal 2017 earnings per American Depositary Share ADS of 42 cents down 16 year over year While quarterly revenues declined 6 5 year over year to 546 million they were up by 3 on a sequential basis Dr Reddy s share price
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3,2017-02-06 14:27:02 +0000,http://finance.yahoo.com/news/dr-reddys-rdy-earnings-revenues-142702615.html,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3,2017-02-06 14:27:02 +0000,http://finance.yahoo.com/news/dr-reddys-rdy-earnings-revenues-142702615.html?.tsrc=rss,"Dr. Reddy's Laboratories Ltd. (RDY) reported third-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 42 cents, down 16% year over year."
RDY,RDY:US,BBG000NJ96L6,Sensex Hits Four-month High On Rate Cut Hopes; Nifty Closes Above 8800,2017-02-06 06:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJrb03-ItI4/sensex-hits-fourmonth-high-on-rate-cut-hopes-nifty-closes-above-8800-20170206-00251,Sensex Hits Four-month High On Rate Cut Hopes; Nifty Closes Above 8800
RDY,RDY:US,BBG000NJ96L6,"Sensex Up 205 Points; Nifty Climbs Above 8,800",2017-02-05 23:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ehl5p3cPTLc/sensex-up-205-points-nifty-climbs-above-8800-20170205-00109,"Sensex Up 205 Points; Nifty Climbs Above 8,800"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Up On Firm Global Cues",2017-02-05 21:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Fjct36NPr8/sensex-nifty-seen-up-on-firm-global-cues-20170205-00087,"Sensex, Nifty Seen Up On Firm Global Cues"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q3 and 9M FY17 Financial Results,2017-02-04 14:52:00 +0000,http://finance.yahoo.com/news/dr-reddy-q3-9m-fy17-145200593.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the third quarter and nine months ended December 31, 2016 under International Financial Reporting Standards ."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q3 and 9M FY17 Financial Results,2017-02-04 14:52:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-q3-9m-fy17-145200418.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the third quarter and nine months ended ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's December quarter net profit fell 16 pct,2017-02-04 08:46:47 +0000,http://in.finance.yahoo.com/news/dr-reddys-december-quarter-net-084647758.html,Dr. Reddy's December quarter net profit fell 16 pct
RDY,RDY:US,BBG000NJ96L6,"Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, PixarBio Corporation and Yahoo! Inc.",2017-02-03 22:01:00 +0000,http://finance.yahoo.com/news/lifshitz-miller-llp-announces-investigation-220100064.html?.tsrc=rss,"NEW YORK, Feb. 3, 2017 /PRNewswire/ -- Dr. Reddy's Laboratories Limited (RDY) Lifshitz & Miller announces investigation on behalf of RDY investors concerning the warning letter RDY received from the FDA ..."
RDY,RDY:US,BBG000NJ96L6,"Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, PixarBio Corporation and Yahoo! Inc.",2017-02-03 22:01:00 +0000,http://finance.yahoo.com/news/lifshitz-miller-llp-announces-investigation-220100064.html,"[PR Newswire] - NEW YORK, Feb. 3, 2017 /PRNewswire/ -- Dr. Reddy's Laboratories Limited (RDY) Lifshitz & Miller announces investigation on behalf of RDY investors concerning the warning letter RDY received from the FDA ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Lackluster Session Flat",2017-02-03 06:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u16GmMNcrWI/sensex-nifty-end-lackluster-session-flat-20170203-00217,"Sensex, Nifty End Lackluster Session Flat"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories (RDY) Shares Cross Above 200 DMA,2017-02-02 22:31:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WsZ01XnXBk8/dr-reddys-laboratories-rdy-shares-cross-above-200-dma-cm742520,In trading on Thursday shares of Dr Reddy s Laboratories Ltd Symbol RDY crossed above their 200 day moving average of 46 51 changing hands as high as 46 77 per share Dr Reddy s Laboratories Ltd shares are currently trading up about 3 1 on the day The chart below shows the one
RDY,RDY:US,BBG000NJ96L6,Sensex Soars 485 Points As Investors Cheer Budget; Nifty Ends At 8716,2017-02-01 06:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3mZAuXQJ9Cw/sensex-soars-485-points-as-investors-cheer-budget-nifty-ends-at-8716-20170201-00256,Sensex Soars 485 Points As Investors Cheer Budget; Nifty Ends At 8716
RDY,RDY:US,BBG000NJ96L6,Top 10 Pharmaceutical Companies In India,2017-01-31 17:08:53 +0000,http://www.insidermonkey.com/blog/top-10-pharmaceutical-companies-in-india-527303/,Top 10 Pharmaceutical Companies In India
RDY,RDY:US,BBG000NJ96L6,Top 10 Pharmaceutical Companies In India,2017-01-31 17:08:53 +0000,http://finance.yahoo.com/r/1329480f-214e-3b59-8f86-846387c52343/top-10-pharmaceutical-companies-in-india-527303?yptr=yahoo&.tsrc=rss,"The top 10 pharmaceutical companies in India operate mainly in the generic drugs segment. Revenue from generic drugs forms the largest segment, accounting for 70% of the total Indian pharmaceutical sector. India produces drugs not only for domestic consumption but also for exports, given its expertise in making cheap, low-cost medicine. The country has made […]"
RDY,RDY:US,BBG000NJ96L6,Blog Coverage Teva Announced FDA Approval for Two Asthma Products; Plans to Appeal Court Decision on COPAXONE,2017-01-31 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-teva-announced-fda-131500248.html,"[Accesswire] - Upcoming AWS Coverage on Dr. Reddy's Laboratories Post-Earnings Results LONDON, UK / ACCESSWIRE / January 31, 2017 / Active Wall St. blog coverage looks at the headline from Teva Pharmaceutical Industries ..."
RDY,RDY:US,BBG000NJ96L6,Blog Coverage Teva Announced FDA Approval for Two Asthma Products; Plans to Appeal Court Decision on COPAXONE,2017-01-31 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-teva-announced-fda-131500248.html?.tsrc=rss,"Upcoming AWS Coverage on Dr. Reddy's Laboratories Post-Earnings Results LONDON, UK / ACCESSWIRE / January 31, 2017 / Active Wall St. blog coverage looks at the headline from Teva Pharmaceutical Industries ..."
RDY,RDY:US,BBG000NJ96L6,"Johnson & Weaver, LLP Announces Investigations of Pearson plc., BT Group plc, Dr. Reddy's Laboratories Ltd. and OneMain Holdings, Inc.",2017-01-25 20:40:00 +0000,http://finance.yahoo.com/news/johnson-weaver-llp-announces-investigations-204000865.html,"[PR Newswire] - Shareholder rights law firm Johnson & Weaver, LLP continues its investigation of potential violations of the federal securities laws by Pearson plc (PSO) and certain of its officers. On January 18, 2017, Pearson said that its initial projections about its U.S. educational business had been too high and students are balking at paying top-dollar for textbooks when more affordable alternatives to outright purchases are available."
RDY,RDY:US,BBG000NJ96L6,"Johnson & Weaver, LLP Announces Investigations of Pearson plc., BT Group plc, Dr. Reddy's Laboratories Ltd. and OneMain Holdings, Inc.",2017-01-25 20:40:00 +0000,http://finance.yahoo.com/news/johnson-weaver-llp-announces-investigations-204000865.html?.tsrc=rss,"Shareholder rights law firm Johnson & Weaver, LLP continues its investigation of potential violations of the federal securities laws by Pearson plc (PSO) and certain of its officers.  On January 18, 2017, Pearson said that its initial projections about its U.S. educational business had been too high and students are balking at paying top-dollar for textbooks when more affordable alternatives to outright purchases are available."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Limited (RDY)",2017-01-24 17:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-170300159.html,"[PR Newswire] - NEW YORK, Jan. 24, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy's Laboratories Limited (""Dr. ..."
RDY,RDY:US,BBG000NJ96L6,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Limited (RDY)",2017-01-24 17:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-170300159.html?.tsrc=rss,"NEW YORK, Jan. 24, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy's Laboratories Limited (""Dr. ..."
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Investigation of Dr. Reddy’s Laboratories Announced by Holzer & Holzer,2017-01-24 13:00:00 +0000,http://finance.yahoo.com/news/investor-alert-investigation-dr-reddy-130000953.html?.tsrc=rss,"Holzer & Holzer, LLC is investigating whether certain statements issued during 2015 by Dr. Reddy’s Laboratories Limited complied with federal securities laws."
RDY,RDY:US,BBG000NJ96L6,INVESTOR ALERT: Investigation of Dr. Reddy’s Laboratories Announced by Holzer & Holzer,2017-01-24 13:00:00 +0000,http://finance.yahoo.com/news/investor-alert-investigation-dr-reddy-130000953.html,"[Business Wire] - Holzer & Holzer, LLC is investigating whether certain statements issued during 2015 by Dr. Reddy’s Laboratories Limited complied with federal securities laws."
RDY,RDY:US,BBG000NJ96L6,"Pre-Market Most Active for Jan 23, 2017 :  INFY, VALE, QCOM, FIT, TVIX, AZN, RDY, BAC, QQQ, AAPL, UGLD, CYNO",2017-01-23 13:57:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f7TaJuaqPkc/pre-market-most-active-for-jan-23-2017-infy-vale-qcom-fit-tvix-azn-rdy-bac-qqq-aapl-ugld-cyno-cm736533,The NASDAQ 100 Pre Market Indicator is down 4 51 to 5 058 69 The total Pre Market volume is currently 6 001 715 shares traded The following are the most active stocks for the pre market session Infosys Limited INFY is 0 4385 at 13 92 with 1 572 008 shares
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's to Release Q3 FY17 Results on Feb 4, 2017",2017-01-23 06:49:00 +0000,http://finance.yahoo.com/news/dr-reddys-release-q3-fy17-064900228.html?.tsrc=rss,"Dr. Reddy's Laboratories will announce results for the Third Quarter and 9 months ended December 31, 2016 on Saturday, February 4, 2017 after the Board Meeting."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's to Release Q3 FY17 Results on Feb 4, 2017",2017-01-23 06:49:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-release-q3-fy17-064900041.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the Third Quarter and 9 months ended December 31, 2016 on Saturday, February ..."
RDY,RDY:US,BBG000NJ96L6,Sensex Rises 40 Points; Nifty Flat Ahead Of Earnings,2017-01-11 23:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c1x3AD6nSic/sensex-rises-40-points-nifty-flat-ahead-of-earnings-20170111-00940,Sensex Rises 40 Points; Nifty Flat Ahead Of Earnings
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Limited to Present at the J.P. Morgan 35th Annual Healthcare Conference,2017-01-09 14:02:00 +0000,http://finance.yahoo.com/news/dr-reddys-laboratories-limited-present-140200972.html?.tsrc=rss,"Dr. Reddy’s Laboratories Ltd. announced that the Company will present at the J.P. Morgan 35th Annual Healthcare Conference on Tuesday, January 10th, 2017, in San Francisco."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Limited to Present at the J.P. Morgan 35th Annual Healthcare Conference,2017-01-09 14:02:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-limited-present-140200828.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that the Company will present at the J.P. Morgan 35 th Annual Healthcare ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex Slips 32 Points; Nifty Closes At 8,236",2017-01-09 05:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZD4xf13j5VE/sensex-slips-32-points-nifty-closes-at-8236-20170109-00103,"Sensex Slips 32 Points; Nifty Closes At 8,236"
RDY,RDY:US,BBG000NJ96L6,Bullish Two Hundred Day Moving Average Cross - RDY,2017-01-05 17:39:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FqlLQz8v7X0/bullish-two-hundred-day-moving-average-cross-rdy-cm729901,In trading on Thursday shares of Dr Reddy s Laboratories Ltd Symbol RDY crossed above their 200 day moving average of 46 65 changing hands as high as 46 84 per share Dr Reddy s Laboratories Ltd shares are currently trading up about 1 7 on the day The chart below shows the one
RDY,RDY:US,BBG000NJ96L6,"The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen",2017-01-04 16:42:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4dVoICHOy0E/the-zacks-analyst-blog-highlights-sucampo-pharmaceuticals-dr-reddys-laboratories-biomarin-pharmaceutical-and-repligen-cm729418,For Immediate Release Chicago IL January 04 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
RDY,RDY:US,BBG000NJ96L6,"The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen",2017-01-04 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-sucampo-143002818.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen"
RDY,RDY:US,BBG000NJ96L6,"The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen",2017-01-04 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-sucampo-143002818.html,"The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen"
RDY,RDY:US,BBG000NJ96L6,3 Overlooked Drug Stocks to Watch Out for in 2017,2017-01-03 15:01:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mAFvUeim7xQ/3-overlooked-drug-stocks-to-watch-out-for-in-2017-cm728634,2016 was a rough year for the medical sector especially biotech stocks with the NASDAQ Biotechnology index declining 19 1 during the year while the NYSE ARCA Pharmaceutical Index was down 9 7 The pharma biotech sector faced several headwinds last year including slow product launches fewer
RDY,RDY:US,BBG000NJ96L6,3 Overlooked Drug Stocks to Watch Out for in 2017,2017-01-03 13:32:01 +0000,http://finance.yahoo.com/news/3-overlooked-drug-stocks-watch-133201454.html,3 Overlooked Drug Stocks to Watch Out for in 2017
RDY,RDY:US,BBG000NJ96L6,Here's Why Sucampo Pharmaceuticals Is Down Over 20% Today,2016-12-20 21:57:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H9qOpfWiosU/heres-why-sucampo-pharmaceuticals-is-down-over-20-today-cm724281,Image source Getty Images What happened Shares of Sucampo Pharmaceuticals NASDAQ SCMP dropped over 20 as of 2 45 p m EST Tuesday after the company announced its intention to sell 225 million in debt notes An option to sell an additional 33 75 million in debt would
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Hit Two-week Lows",2016-12-19 06:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jgB1YlSXomA/sensex-nifty-hit-twoweek-lows-20161219-00132,"Sensex, Nifty Hit Two-week Lows"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Decline After U.S. Fed Rate Hike",2016-12-15 07:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/965ts6Ne1o8/sensex-nifty-decline-after-us-fed-rate-hike-20161215-00230,"Sensex, Nifty Decline After U.S. Fed Rate Hike"
RDY,RDY:US,BBG000NJ96L6,Should You Buy Vedanta Ltd (ADR) (VEDL)?,2016-12-13 21:13:17 +0000,http://www.insidermonkey.com/blog/should-you-buy-vedanta-ltd-adr-vedl-507941/,Should You Buy Vedanta Ltd (ADR) (VEDL)?
RDY,RDY:US,BBG000NJ96L6,Should You Buy Vedanta Ltd (ADR) (VEDL)?,2016-12-13 21:13:17 +0000,http://finance.yahoo.com/r/1c6fe11f-d85a-3016-b9f4-2be4f3d313ab/should-you-buy-vedanta-ltd-adr-vedl-507941?yptr=yahoo&.tsrc=rss,Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the […]
RDY,RDY:US,BBG000NJ96L6,"Asian ADRs Inch Lower as Chinese Retailers, Asian Tech Stocks Slip",2016-12-12 15:56:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F09AksNY4Sc/asian-adrs-inch-lower-as-chinese-retailers-asian-tech-stocks-slip-cm720094,American depository receipts of Asian stocks were down 0 53 to 147 25 in U S trading on Monday according to the BNY Mellon Asia ADR Index American depository receipts of Asian stocks were down 0 53 to 147 25 in U S trading on Monday according to the BNY Mellon Asia ADR Index Decliners
RDY,RDY:US,BBG000NJ96L6,Moody's and ICRA: Indian pharmaceutical generics majors' growth will be driven by M&As,2016-12-12 02:04:03 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_359300&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20161211_PR_359300,Moody's and ICRA: Indian pharmaceutical generics majors' growth will be driven by M&As
RDY,RDY:US,BBG000NJ96L6,Do Hedge Funds Love Atmos Energy Corporation (ATO)?,2016-12-09 10:46:29 +0000,http://www.insidermonkey.com/blog/do-hedge-funds-love-atmos-energy-corporation-ato-503299/,Do Hedge Funds Love Atmos Energy Corporation (ATO)?
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market",2016-12-05 06:42:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-064200000.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Nystatin and Triamcinolone Acetonide Cream, ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Marginally Lower In Choppy Trade",2016-12-04 23:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zaiPoSWRHD0/sensex-nifty-marginally-lower-in-choppy-trade-20161204-00075,"Sensex, Nifty Marginally Lower In Choppy Trade"
RDY,RDY:US,BBG000NJ96L6,Arch Capital Group Ltd. (ACGL): Are Hedge Funds Right About This Stock?,2016-12-02 07:11:41 +0000,http://www.insidermonkey.com/blog/arch-capital-group-ltd-acgl-are-hedge-funds-right-about-this-stock-496449/,Arch Capital Group Ltd. (ACGL): Are Hedge Funds Right About This Stock?
RDY,RDY:US,BBG000NJ96L6,Is Newfield Exploration Co. (NFX) A Good Stock To Buy Right Now?,2016-12-01 14:13:00 +0000,http://www.insidermonkey.com/blog/is-newfield-exploration-co-nfx-a-good-stock-to-buy-right-now-491496/,Is Newfield Exploration Co. (NFX) A Good Stock To Buy Right Now?
RDY,RDY:US,BBG000NJ96L6,How One Woman Silenced Her Twitter Trolls With a 78% Stock Rally,2016-11-30 21:00:00 +0000,http://www.bloomberg.com/news/articles/2016-11-30/how-one-woman-shut-up-her-twitter-trolls-with-pharma-stock-rally?cmpid=yhoo.headline,How One Woman Silenced Her Twitter Trolls With a 78% Stock Rally
RDY,RDY:US,BBG000NJ96L6,How to Invest in Bombay Stock Exchange Companies,2016-11-29 19:54:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NvO0QgAoS2Q/how-to-invest-in-bombay-stock-exchange-companies-cm715307,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips If you want to invest in Indian stocks like those that list on the Bombay Stock Exchange BSE or National Stock Exchange NSE well I can t blame you But you might want to bone up on your
RDY,RDY:US,BBG000NJ96L6,Is Coty Inc (COTY) a Good Stock To Buy?,2016-11-29 19:00:34 +0000,http://www.insidermonkey.com/blog/is-coty-inc-coty-a-good-stock-to-buy-490724/,Is Coty Inc (COTY) a Good Stock To Buy?
RDY,RDY:US,BBG000NJ96L6,Will Demonetization in India Impact Your Loan Burden?,2016-11-23 15:04:45 +0000,http://marketrealist.com/2016/11/will-demonetization-india-impact-loan-burden/?utm_source=yahoo&utm_medium=feed,Will Demonetization in India Impact Your Loan Burden?
RDY,RDY:US,BBG000NJ96L6,"Pre-Market Most Active for Nov 23, 2016 :  LLY, DE, RDY, NVO, BIIB, ERIC, MT, SNY, JUNO, QQQ, XIV, TVIX",2016-11-23 13:53:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kID8OF6hPdw/pre-market-most-active-for-nov-23-2016-lly-de-rdy-nvo-biib-eric-mt-sny-juno-qqq-xiv-tvix-cm713147,The NASDAQ 100 Pre Market Indicator is down 12 65 to 4 861 19 The total Pre Market volume is currently 9 642 054 shares traded The following are the most active stocks for the pre market session Eli Lilly and Company LLY is 10 22 at 65 77 with 3 698 726
RDY,RDY:US,BBG000NJ96L6,Notable Two Hundred Day Moving Average Cross - RDY,2016-11-18 17:50:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wlU3FgxFfnI/notable-two-hundred-day-moving-average-cross-rdy-cm711293,In trading on Friday shares of Dr Reddy s Laboratories Ltd Symbol RDY crossed below their 200 day moving average of 46 56 changing hands as low as 46 41 per share Dr Reddy s Laboratories Ltd shares are currently trading down about 1 3 on the day The chart below shows the one
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Slip Into Red After Flat Start",2016-11-17 23:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r91UpK_crpA/sensex-nifty-slip-into-red-after-flat-start-20161117-01433,"Sensex, Nifty Slip Into Red After Flat Start"
RDY,RDY:US,BBG000NJ96L6,"Sensex Plunges 514 Points On Capital Outflow Worries; Nifty Nears 8,200",2016-11-15 06:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nEkjj2EYQS4/sensex-plunges-514-points-on-capital-outflow-worries-nifty-nears-8200-20161115-00229,"Sensex Plunges 514 Points On Capital Outflow Worries; Nifty Nears 8,200"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Labs Launches New Drug (RDY),2016-11-14 16:00:00 +0000,http://www.investopedia.com/news/dr-reddys-opens-drug-us-market-rdy/?partner=YahooSA,Dr. Reddy’s Labs Launches New Drug (RDY)
RDY,RDY:US,BBG000NJ96L6,Blog Coverage Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US,2016-11-14 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-dr-reddys-labs-131500957.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / November 14, 2016 / Active Wall St. blog coverage looks at the headline from Dr. Reddy's Laboratories Ltd (NYSE: RDY ) as the company announced on November 11, 2016, that it had ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories announces the launch of Raloxifene HCl Tablets, USP in the U.S. Market",2016-11-11 10:47:08 +0000,http://www.publicnow.com/view/F999123F781189E260108B8D812B7690DBFBD296,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40- 49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Raloxifene HCl Tablets, USP in the U.S. Market",2016-11-11 10:20:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-102000100.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Raloxifene hydrochloride tablets in 60 mg, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy''s Labs Launches Raloxifene HCl Tablets, USP In U.S. Market",2016-11-11 05:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uc9algUeHHE/dr-reddys-labs-launches-raloxifene-hcl-tablets-usp-in-us-market-20161111-00094,"Dr. Reddy''s Labs Launches Raloxifene HCl Tablets, USP In U.S. Market"
RDY,RDY:US,BBG000NJ96L6,"Sucampo (SCMP) Beats Q3 Earnings & Revenues, Guides Up",2016-11-10 15:57:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EgcWc_-1tgg/sucampo-scmp-beats-q3-earnings-revenues-guides-up-cm707107,Sucampo SCMP reported earnings of 28 cents per share in the third quarter of 2016 beating the Zacks Consensus Estimate of 26 cents by 7 7 Reported earnings were also up by 68 from the year ago figure of 17 cents FindTheCompany Graphiq Total revenue came in at 57
RDY,RDY:US,BBG000NJ96L6,India Stocks Rally On Rupee Reform,2016-11-09 19:20:00 +0000,http://blogs.barrons.com/emergingmarketsdaily/2016/11/09/india-stocks-rally-on-rupee-reform/?mod=yahoobarrons&ru=yahoo,India Stocks Rally On Rupee Reform
RDY,RDY:US,BBG000NJ96L6,"Sensex Drops 156 Points As Pharma Stocks Take A Hit; Nifty Ends At 8,433",2016-11-04 07:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kllU-dcpVxg/sensex-drops-156-points-as-pharma-stocks-take-a-hit-nifty-ends-at-8433-20161104-00583,"Sensex Drops 156 Points As Pharma Stocks Take A Hit; Nifty Ends At 8,433"
RDY,RDY:US,BBG000NJ96L6,Generic Drug Firms Face Possible Collusion Charges -- WSJ,2016-11-04 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/78-5RUwZImE/generic-drug-firms-face-possible-collusion-charges--wsj-20161104-00491,Generic Drug Firms Face Possible Collusion Charges -- WSJ
RDY,RDY:US,BBG000NJ96L6,Generic-Drug Firms Face Possible Collusion Charges -- 1st update,2016-11-03 20:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-bOvVSAKTss/genericdrug-firms-face-possible-collusion-charges--1st-update-20161103-01236,Generic-Drug Firms Face Possible Collusion Charges -- 1st update
RDY,RDY:US,BBG000NJ96L6,Generic-Drug Firms Face Possible Collusion Charges,2016-11-03 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q_BrV9vSKks/genericdrug-firms-face-possible-collusion-charges-20161103-01241,Generic-Drug Firms Face Possible Collusion Charges
RDY,RDY:US,BBG000NJ96L6,Generic Drug Firms Face Possible Collusion Charges,2016-11-03 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kn4Mp2kihCw/generic-drug-firms-face-possible-collusion-charges-20161103-01234,Generic Drug Firms Face Possible Collusion Charges
RDY,RDY:US,BBG000NJ96L6,Generic-Drug Makers' Shares Drop on Report of Possible Probe,2016-11-03 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qi3HbUrZ900/genericdrug-makers-shares-drop-on-report-of-possible-probe-20161103-01235,Generic-Drug Makers' Shares Drop on Report of Possible Probe
RDY,RDY:US,BBG000NJ96L6,Generic-Drug Makers'' Shares Drop on Report of Possible Probe,2016-11-03 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdznyXa-NO0/genericdrug-makers-shares-drop-on-report-of-possible-probe-20161103-01155,Generic-Drug Makers'' Shares Drop on Report of Possible Probe
RDY,RDY:US,BBG000NJ96L6,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : October 28, 2016",2016-10-28 19:16:13 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-dr-reddys-laboratories-ltd-october-28-2016/,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : October 28, 2016"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q2, 2017 By the Numbers : October 27, 2016",2016-10-27 13:50:42 +0000,http://www.capitalcube.com/blog/index.php/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-q2-2017-by-the-numbers-october-27-2016/,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q2, 2017 By the Numbers : October 27, 2016"
RDY,RDY:US,BBG000NJ96L6,"Sensex Snaps Two-day Losing Streak, Nifty Ends Flat",2016-10-27 07:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TWjfsmFipfY/sensex-snaps-twoday-losing-streak-nifty-ends-flat-20161027-02040,"Sensex Snaps Two-day Losing Streak, Nifty Ends Flat"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2,2016-10-26 15:53:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GHhuVeh21MY/dr-reddys-rdy-earnings-revenues-decline-yy-in-q2-cm698533,Dr Reddy s Laboratories Ltd RDY reported second quarter fiscal 2017 earnings per American Depositary Share ADS of 27 cents down 57 1 year over year Moreover quarterly revenues declined 10 year over year to 539 million primarily due to lower contribution from all its
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces New Strategic Deal with Gland Pharma in the U.S. Market,2016-10-26 13:58:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-strategic-135800731.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has entered into a strategic collaboration with Gland Pharma, ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2,2016-10-26 13:48:01 +0000,http://finance.yahoo.com/news/dr-reddys-rdy-earnings-revenues-134801677.html,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2
RDY,RDY:US,BBG000NJ96L6,What Gives? Dr. Reddy's Shares Jump 6% Despite Earnings Miss,2016-10-25 17:56:00 +0000,http://blogs.barrons.com/emergingmarketsdaily/2016/10/25/what-gives-dr-reddys-shares-jump-6-despite-earnings-miss/?mod=yahoobarrons&ru=yahoo,What Gives? Dr. Reddy's Shares Jump 6% Despite Earnings Miss
RDY,RDY:US,BBG000NJ96L6,Health Care Sector Update for 10/25/2016: RDY,2016-10-25 13:44:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Js-hx9zsCDs/health-care-sector-update-for-10252016-rdy-cm697685,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE flatPFE flat ABT 0 7 ABT 0 7 MRK 0 8 MRK 0 8 AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Tuesday Health care shares were mainly unchanged in pre market trade on Tuesday
RDY,RDY:US,BBG000NJ96L6,Doctor Reddy's posts 2Q profit,2016-10-25 10:48:24 +0000,http://sg.finance.yahoo.com/news/doctor-reddys-posts-2q-profit-104824063.html,Doctor Reddy's posts 2Q profit
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q2 and H1 FY17 Financial Results,2016-10-25 10:37:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-q2-h1-fy17-103700081.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the second quarter and half year ended September ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy''s Laboratories Q2 17 Earnings Conference Call At 9:00 AM ET,2016-10-25 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nFgOesKUpQ0/dr-reddys-laboratories-q2-17-earnings-conference-call-at-900-am-et-20161025-00472,Dr. Reddy''s Laboratories Q2 17 Earnings Conference Call At 9:00 AM ET
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q2 and H1 FY17 Financial Results,2016-10-25 07:21:04 +0000,http://www.publicnow.com/view/39E3DF87AB9F990E674A1D03444D052D8783D413,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-4900 2135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,Dr Reddy's profit misses view as emerging markets sales fall,2016-10-25 06:37:38 +0000,http://in.finance.yahoo.com/news/dr-reddys-q2-profit-misses-060134591.html,Dr Reddy's profit misses view as emerging markets sales fall
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty To Start Week On Positive Footing",2016-10-23 22:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vc084a6Ltnc/sensex-nifty-to-start-week-on-positive-footing-20161023-00043,"Sensex, Nifty To Start Week On Positive Footing"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Off Day''s Lows",2016-10-21 07:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4gZBwzJhhVI/sensex-nifty-end-off-days-lows-20161021-00170,"Sensex, Nifty End Off Day''s Lows"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. : RDY-US: Dividend Analysis : July 18th, 2016 (record date) : By the numbers : October 19, 2016",2016-10-19 17:48:05 +0000,http://www.capitalcube.com/blog/index.php/dr-reddys-laboratories-ltd-rdy-us-dividend-analysis-july-18th-2016-record-date-by-the-numbers-october-19-2016/,"Dr. Reddy’s Laboratories Ltd. : RDY-US: Dividend Analysis : July 18th, 2016 (record date) : By the numbers : October 19, 2016"
RDY,RDY:US,BBG000NJ96L6,Are toxic lakes the cost of cheap drugs?,2016-10-18 02:01:44 +0000,http://au.finance.yahoo.com/news/toxic-lakes-cost-cheap-drugs-020144900.html,"[AAP] - Centuries ago, Indian princes would bathe in the cool Kazhipally lake in Medak. Now, even the poorest villagers here in India's baking south point to the barren banks and frothy water and say they avoid going anywhere near it. A short drive from the bustling tech hub of Hyderabad, Medak is the heart of India's antibiotics manufacturing business: a district of about 2.5 million that has become one of the world's largest suppliers of cheap drugs to most markets, including the United States."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's to Release Q2 FY17 Results on Oct 25, 2016; Earnings Call Slated for Oct 25, 6.30 PM IST / 9.00 AM EDT",2016-10-14 16:24:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-release-q2-fy17-162400409.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the Second Quarter ended September 30, 2016 on Tuesday, October 25, 2016 after ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Aripiprazole Tablets, USP Tablets in the U.S. Market",2016-10-13 10:44:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-104400114.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Aripiprazole tablets, USP, in 2 mg, 5 mg, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories announces the launch of Aripiprazole tablets, USP tablets in the U.S. Market",2016-10-13 10:30:05 +0000,http://www.publicnow.com/view/1CA2B6537BB961DB2B07EEDB1E8A23A8CB08139A,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy''s Labs Launches Aripiprazole Tablets, USP Tablets In U.S.",2016-10-13 06:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WT86LktMKbw/dr-reddys-labs-launches-aripiprazole-tablets-usp-tablets-in-us-20161013-00209,"Dr. Reddy''s Labs Launches Aripiprazole Tablets, USP Tablets In U.S."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories announces the launch of Lamotrigine Orally Disintegrating Tablets in the U.S. Market,2016-10-12 11:13:07 +0000,http://www.publicnow.com/view/F749D0B37306DFEF90E8CE1989C4ADDBD0F9DC1A,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : October 10, 2016",2016-10-10 14:01:36 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-dr-reddys-laboratories-ltd-october-10-2016/,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : October 10, 2016"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Lamotrigine Orally Disintegrating Tablets in the U.S. Market,2016-10-10 12:19:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-121900073.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Lamotrigine Orally Disintegrating Tablets ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy''s Labs Launches Lamotrigine Orally Disintegrating Tablets In U.S.,2016-10-10 08:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gp950eJKGZY/dr-reddys-labs-launches-lamotrigine-orally-disintegrating-tablets-in-us-20161010-00303,Dr. Reddy''s Labs Launches Lamotrigine Orally Disintegrating Tablets In U.S.
RDY,RDY:US,BBG000NJ96L6,"Leading global pharmaceutical company, Dr. Reddy’s Laboratories now in Colombia",2016-10-10 08:13:02 +0000,http://www.publicnow.com/view/004C8F24620F5131FF4F806A6A7189879B56E979,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,Sensex Rises 65 Points In Early Trade; Nifty Up 26 Points,2016-10-10 00:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SSqySud42kc/sensex-rises-65-points-in-early-trade-nifty-up-26-points-20161010-00004,Sensex Rises 65 Points In Early Trade; Nifty Up 26 Points
RDY,RDY:US,BBG000NJ96L6,Indian Equities Rise after the RBI’s October 2016 Monetary Policy Announcement,2016-10-05 19:04:08 +0000,http://marketrealist.com/2016/10/indian-equities-rise-post-october-2016-monetary-policy-announcement/?utm_source=yahoo&utm_medium=feed,Indian Equities Rise after the RBI’s October 2016 Monetary Policy Announcement
RDY,RDY:US,BBG000NJ96L6,Why the RBI Feels that Monetary Policy Transmission Can Improve in India,2016-10-05 18:31:02 +0000,http://marketrealist.com/2016/10/rbi-feels-monetary-policy-transmission-can-improve-india/?utm_source=yahoo&utm_medium=feed,Why the RBI Feels that Monetary Policy Transmission Can Improve in India
RDY,RDY:US,BBG000NJ96L6,"Amgen Expands New Drugs Into Indian Market (AMGN, RDY)",2016-10-03 13:33:00 +0000,http://www.investopedia.com/news/amgen-expands-new-drugs-indian-market-amgn-rdy/?partner=YahooSA,"Amgen Expands New Drugs Into Indian Market (AMGN, RDY)"
RDY,RDY:US,BBG000NJ96L6,"Insight: The cost of cheap drugs? Toxic Indian lake is ""superbug hotspot""",2016-09-29 02:30:41 +0000,http://in.finance.yahoo.com/news/insight-cost-cheap-drugs-toxic-022546875.html,"Insight: The cost of cheap drugs? Toxic Indian lake is ""superbug hotspot"""
RDY,RDY:US,BBG000NJ96L6,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : September 26, 2016",2016-09-26 15:17:38 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-dr-reddys-laboratories-ltd-september-26-2016/,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : September 26, 2016"
RDY,RDY:US,BBG000NJ96L6,Sensex Down 95 Points; Nifty At 8775,2016-09-20 00:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3IftCrOZg58/sensex-down-95-points-nifty-at-8775-20160920-00672,Sensex Down 95 Points; Nifty At 8775
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories announces the launch of Paricalcitol Injection in the U.S. Market,2016-09-19 15:18:02 +0000,http://www.publicnow.com/view/5D781AB3A9A28B7B75B9E4BB6D0BA64E219D2134,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Paricalcitol Injection in the U.S. Market,2016-09-19 12:52:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-125200092.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Paricalcitol Injection, USP, in 2 mcg, 5 mcg, ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Expands Strategic Collaboration with Amgen in India,2016-09-16 12:18:06 +0000,http://www.publicnow.com/view/2F1616764085929F732B59A21273A4A277600BC1,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Expands Collaboration To Market Amgen's 3 Medicines In India,2016-09-16 07:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tj7VE28nyM8/dr-reddys-expands-collaboration-to-market-amgens-3-medicines-in-india-20160916-00150,Dr. Reddy's Expands Collaboration To Market Amgen's 3 Medicines In India
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Expands Collaboration To Market Amgen's 3 Medicines In India,2016-09-16 07:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eRHktKqD_QA/dr-reddys-expands-collaboration-to-market-amgens-3-medicines-in-india-20160916-00741,Dr. Reddy's Expands Collaboration To Market Amgen's 3 Medicines In India
RDY,RDY:US,BBG000NJ96L6,Dr Reddy’s listed on Dow Jones Sustainability Indices 2016,2016-09-14 09:18:05 +0000,http://www.publicnow.com/view/FC418EE079408018B340911CE56693D0BCF99234,"[at noodls] - Press Note CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Drift Lower In Early Trade",2016-09-14 00:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q6GwhWR_EIY/sensex-nifty-drift-lower-in-early-trade-20160914-00006,"Sensex, Nifty Drift Lower In Early Trade"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Drift Lower In Early Trade",2016-09-14 00:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/odJ2zJTyS1A/sensex-nifty-drift-lower-in-early-trade-20160914-00007,"Sensex, Nifty Drift Lower In Early Trade"
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for September 13th,2016-09-13 14:48:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0hiQu831oHM/new-strong-sell-stocks-for-september-13th-cm678614,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today 160 160 160 Baidu Inc BIDU provides Internet search services in China and internationally The Zacks Consensus Estimate for its current year earnings has been revised 0 1 downward over the last 30
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Listed on Dow Jones Sustainability Indices 2016,2016-09-13 09:35:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-listed-dow-jones-093500202.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has been listed as an Index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories announces the launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the U.S. Market",2016-09-06 07:38:01 +0000,http://www.publicnow.com/view/475C7B54441977DF13D8665F8A299C24C0E6A9C7,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the U.S. Market",2016-09-02 15:32:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-153200219.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Bupropion HCl extended-release tablets, USP ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Marginally Higher In Early Trade",2016-09-02 00:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yf2O8A6eShE/sensex-nifty-marginally-higher-in-early-trade-20160902-00008,"Sensex, Nifty Marginally Higher In Early Trade"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s announces Purple Health, a unique patient-centric platform that takes care beyond the pill",2016-09-01 12:13:05 +0000,http://www.publicnow.com/view/2050C3D558E88714C474148469764B1D8C96ADEC,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Announces Purple Health, a Unique Patient-Centric Platform That Takes Care beyond the Pill",2016-09-01 09:43:00 +0000,http://finance.yahoo.com/news/dr-reddy-announces-purple-health-094300485.html,"[Business Wire] - Dr. Reddy’s Laboratories Ltd today announced the launch of Purple Health, a unique platform designed to inspire patient-centric innovation and deliver solutions that address unmet needs of patients."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Announces Purple Health, a Unique Patient-Centric Platform That Takes Care beyond the Pill",2016-09-01 09:43:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-announces-purple-health-094300110.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced the launch of Purple Health, a unique platform designed to inspire patient-centric innovation and deliver solutions that address unmet needs of patients. As the first major initiative under Purple Health, the company launched a new range of innovative, patient-centric packaging that aims to enhance the therapy experience for over 20 million patients each year."
RDY,RDY:US,BBG000NJ96L6,RDY Makes Bullish Cross Above Critical Moving Average,2016-08-30 16:07:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N1YuR0NJneQ/rdy-makes-bullish-cross-above-critical-moving-average-cm672233,"In trading on Tuesday, shares of Dr. Reddy's Laboratories Ltd. (Symbol RDY) crossed above their 200 day moving average of $46.19, changing hands as high as $46.48 per share. Dr. Reddy's Laboratories Ltd. shares are currently trading up about"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories launches Nitroglycerin sublingual tablets USP in the U.S. Market,2016-08-29 10:53:08 +0000,http://www.publicnow.com/view/0C6E18E049365C64981E48112AB075876727763B,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. Market Hyderabad, India, August 29, 2016",2016-08-29 09:23:00 +0000,http://finance.yahoo.com/news/dr-reddys-laboratories-launches-nitroglycerin-092300169.html,"[Business Wire] - Dr. Reddy’s Laboratories Ltd announced today that it has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat® sublingual tablets in the US market on August 26, 2016, having been approved by the United States Food & Drug Administration ."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. Market Hyderabad, India, August 29, 2016",2016-08-29 09:23:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-launches-nitroglycerin-092300896.html,"[Business Wire] - HYDERABAD, India & PRINCETON, NJ--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Nitroglycerin sublingual tablets USP, 0.3 mg, ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Labs Launches Nitroglycerin Sublingual Tablets USP,2016-08-29 05:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lk1wfJttT3E/dr-reddys-labs-launches-nitroglycerin-sublingual-tablets-usp-20160829-00061,Dr. Reddy's Labs Launches Nitroglycerin Sublingual Tablets USP
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for August 24th,2016-08-24 16:43:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/51Y5jlW_opQ/new-strong-sell-stocks-for-august-24th-cm669590,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today   •    Allegiant Travel CompanyALGT is focused on linking travelers in small cities to world class leisure destinations. The Zacks Consensus Estimate
RDY,RDY:US,BBG000NJ96L6,Indian Equities and Funds Fall after the August Monetary Policy,2016-08-11 13:06:39 +0000,http://marketrealist.com/2016/08/indian-equities-funds-fall-august-monetary-policy/?utm_source=yahoo&utm_medium=feed,Indian Equities and Funds Fall after the August Monetary Policy
RDY,RDY:US,BBG000NJ96L6,Efficient Policy Transmission in India Concerns the RBI,2016-08-11 13:06:36 +0000,http://marketrealist.com/2016/08/efficient-policy-transmission-india-concerns-rbi/?utm_source=yahoo&utm_medium=feed,Efficient Policy Transmission in India Concerns the RBI
RDY,RDY:US,BBG000NJ96L6,Reviewing Raghuram Rajan’s Term as the RBI Governor,2016-08-10 15:16:47 +0000,http://marketrealist.com/2016/08/reviewing-raghuram-rajans-term-rbi-governor/?utm_source=yahoo&utm_medium=feed,Reviewing Raghuram Rajan’s Term as the RBI Governor
RDY,RDY:US,BBG000NJ96L6,Asian ADRs Move Higher in Monday Trading,2016-08-08 16:28:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wy05rUtzMBs/asian-adrs-move-higher-in-monday-trading-cm661900,"American depository receipts of Asian stocks were trading 0.62% at 140.94 on the Bank of New York Mellon Asia ADR Index on Monday. In North Asia, the gainers were led by Renren ( RENN ), a social networking platform"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Pare Early Gains",2016-08-08 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qRxng8QO49s/sensex-nifty-pare-early-gains-20160808-00008,"Sensex, Nifty Pare Early Gains"
RDY,RDY:US,BBG000NJ96L6,Asian ADRs Move Higher in Thursday Trading,2016-08-04 15:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iytzPLdqLg4/asian-adrs-move-higher-in-thursday-trading-cm660442,"American depository receipts of Asian stocks were trading 0.66% higher at 138.13 on the Bank of New York Mellon Asia ADR Index on Thursday. In North Asia, the gainers were led by advertising company Airmedia ( AMCN ) which"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s completes acquisition of product portfolio from TEVA,2016-08-04 08:02:12 +0000,http://www.publicnow.com/view/837EA0B35EA5F47CE273469E6E72E8906803EB3D,"[at noodls] - Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS SAUNAK SAVLA saunaks@drreddys.com(Ph: +91-40-49002135) CALVIN PRINTER ... This is an abstract of the original noodl. To continue reading this document, ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Erase Early Gains",2016-08-04 00:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RAvrh1rCQ1w/sensex-nifty-erase-early-gains-20160804-00004,"Sensex, Nifty Erase Early Gains"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA,2016-08-03 17:58:00 +0000,http://finance.yahoo.com/news/dr-reddy-completes-acquisition-product-175800600.html,[Business Wire] - Dr. Reddy’s Laboratories Ltd. today announced that it successfully completed the previously announced acquisition of eight Abbreviated New Drug Applications in the U.S.
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA,2016-08-03 17:58:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-completes-acquisition-product-175800155.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) today announced that it successfully completed the previously announced acquisition ..."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2016",2016-08-03 16:31:55 +0000,http://www.capitalcube.com/blog/index.php/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-q1-2017-by-the-numbers-august-3-2016/,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2016"
RDY,RDY:US,BBG000NJ96L6,Hospital Chain’s CEO Faces Lawsuit Over Business Practices,2016-08-01 11:30:00 +0000,http://www.wsj.com/articles/hospital-chains-ceo-faces-lawsuit-over-business-practices-1470021573?ru=yahoo?mod=yahoo_itp,Hospital Chain’s CEO Faces Lawsuit Over Business Practices
RDY,RDY:US,BBG000NJ96L6,Hospital Chain’s CEO Faces Suit,2016-08-01 01:23:19 +0000,http://online.wsj.com/article/SB21995845847751293922404582201642507819620.html?ru=yahoo?mod=yahoo_itp,Hospital Chain’s CEO Faces Suit
RDY,RDY:US,BBG000NJ96L6,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : July 29, 2016",2016-07-29 17:49:30 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-dr-reddys-laboratories-ltd-july-29-2016/,"ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : July 29, 2016"
RDY,RDY:US,BBG000NJ96L6,New Strong Sell Stocks for July 28th,2016-07-28 14:27:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vIkEySfa2cE/new-strong-sell-stocks-for-july-28th-cm656451,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today •     Dr. Reddy's Laboratories Ltd.RDY is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the
RDY,RDY:US,BBG000NJ96L6,"Correction to Teva, Allergan Article",2016-07-27 19:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bLEIILebwRg/correction-to-teva-allergan-article-20160727-01638,"Correction to Teva, Allergan Article"
RDY,RDY:US,BBG000NJ96L6,"Teva, Allergan Get FTC Approval for Generics Purchase",2016-07-27 15:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H21EvJ1-Duk/teva-allergan-get-ftc-approval-for-generics-purchase-20160727-01145,"Teva, Allergan Get FTC Approval for Generics Purchase"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y,2016-07-27 14:28:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I5eBys_ekgU/dr-reddys-rdy-q1-earnings-and-revenues-decline-yy-cm655643,"Dr. Reddy's Laboratories Ltd.RDY reported first quarter fiscal 2017 earnings per American Depositary Share (ADS) of 11 cents, down 79.6% from the year over year. Moreover, revenues of $479 million reflected a 14% decline from the prior year quarter"
RDY,RDY:US,BBG000NJ96L6,Implied FNI Analyst Target Price: $32,2016-07-27 13:26:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i9m1AbyRfE0/implied-fni-analyst-target-price-32-cm655446,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y,2016-07-27 13:10:01 +0000,http://finance.yahoo.com/news/dr-reddys-rdy-q1-earnings-131001709.html,Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's downgraded by Jefferies and HSBC Securities,2016-07-27 11:18:54 +0000,http://finance.yahoo.com/q/ud?s=RDY,Dr. Reddy's downgraded by Jefferies and HSBC Securities
RDY,RDY:US,BBG000NJ96L6,Sensex Up 142 Points In Early Trade; Nifty At 8641,2016-07-27 00:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QoLdCmxIVV8/sensex-up-142-points-in-early-trade-nifty-at-8641-20160727-00006,Sensex Up 142 Points In Early Trade; Nifty At 8641
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Ltd (ADR) Is Tanking Today -- Here's Why,2016-07-26 22:23:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OirZkr8WR5c/dr-reddys-laboratories-ltd-adr-is-tanking-today-heres-why-cm655226,Image source  Getty Images.  What  Investors in Indian drugmaker Dr. Reddy's Labs (NYSE  RDY) are having a rough day. The company's stock has plunged by more than 18% as of 2
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Tumbles On 1Q Earnings, Venezuela Losses",2016-07-26 21:49:00 +0000,http://blogs.barrons.com/emergingmarketsdaily/2016/07/26/dr-reddys-tumbles-on-1q-earnings-venezuela-losses/?mod=yahoobarrons&ru=yahoo,"Dr. Reddy's Tumbles On 1Q Earnings, Venezuela Losses"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Ltd (ADR) Is Tanking Today -- Here's Why,2016-07-26 20:26:00 +0000,http://www.fool.com/investing/2016/07/26/why-dr-reddys-labs-is-tanking-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Dr. Reddy's Laboratories Ltd (ADR) Is Tanking Today -- Here's Why
RDY,RDY:US,BBG000NJ96L6,"Health Care Sector Update for 07/26/2016: RDY,ALIM,TKAI",2016-07-26 20:22:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CdwpgAZnlbo/health-care-sector-update-for-07262016-rdyalimtkai-cm655158,"Top Health Care Stocks JNJ +0.17% PFE 0.01% MRK +0.31% ABT 0.43% AMGN +0.64% Health care stocks were mixed in late day trade, with the NYSE Health Care Index rising about 0.1% while shares of health care companies in"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q1 FY17 Financial Results,2016-07-26 18:03:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-q1-fy17-financial-180300393.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY): Revenues at Rs. 32.3 billion (YoY decline of 14%) EBITDA at Rs. 4.0 billion (12.3% of ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Breaks Below 200-Day Moving Average - Notable for RDY,2016-07-26 16:22:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byjSCod-nAI/dr-reddys-laboratories-breaks-below-200-day-moving-average-notable-for-rdy-cm654874,"In trading on Tuesday, shares of Dr. Reddy's Laboratories Ltd. (Symbol RDY) crossed below their 200 day moving average of $48.59, changing hands as low as $45.31 per share. Dr. Reddy's Laboratories Ltd. shares are currently trading off about"
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016",2016-07-26 13:26:11 +0000,http://www.capitalcube.com/blog/index.php/dr-reddys-laboratories-ltd-rdy-us-earnings-analysis-2016-by-the-numbers-july-26-2016/,"Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016"
RDY,RDY:US,BBG000NJ96L6,"Dr Reddy's Labs Q1 profit slumps 75 percent, misses estimates",2016-07-26 09:29:11 +0000,http://in.finance.yahoo.com/news/dr-reddys-labs-q1-profit-092911694.html,"Dr Reddy's Labs Q1 profit slumps 75 percent, misses estimates"
RDY,RDY:US,BBG000NJ96L6,Sensex Dips Over 100 Points; Nifty Closes Below 8600,2016-07-26 07:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MPSuknRlnrc/sensex-dips-over-100-points-nifty-closes-below-8600-20160726-00336,Sensex Dips Over 100 Points; Nifty Closes Below 8600
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Hold Steady In Early Trade",2016-07-26 00:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9wglFUZxDo/sensex-nifty-hold-steady-in-early-trade-20160726-00002,"Sensex, Nifty Hold Steady In Early Trade"
RDY,RDY:US,BBG000NJ96L6,Sensex Breaches 28000; Nifty Hits 52-week High To Close Above 8600,2016-07-25 07:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I73Ut7wpUok/sensex-breaches-28000-nifty-hits-52week-high-to-close-above-8600-20160725-00204,Sensex Breaches 28000; Nifty Hits 52-week High To Close Above 8600
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Seen Flat To Higher",2016-07-24 22:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2r-M3LP7ukA/sensex-nifty-seen-flat-to-higher-20160724-00057,"Sensex, Nifty Seen Flat To Higher"
RDY,RDY:US,BBG000NJ96L6,"Sensex Rises 128 Points; Nifty Climbs Above 8,560",2016-07-20 07:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FIDQmAdBiAo/sensex-rises-128-points-nifty-climbs-above-8560-20160720-00281,"Sensex Rises 128 Points; Nifty Climbs Above 8,560"
RDY,RDY:US,BBG000NJ96L6,Will India Benefit from the Brexit Vote?,2016-07-18 16:19:36 +0000,http://marketrealist.com/2016/07/will-india-benefit-brexit-vote/?utm_source=yahoo&utm_medium=feed,Will India Benefit from the Brexit Vote?
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories Announces the Launch of Omeprazole and Sodium bicarbonate Capsules in the U.S. Market,2016-07-18 06:43:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-laboratories-announces-launch-064300282.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Omeprazole and Sodium bicarbonate capsules, ..."
RDY,RDY:US,BBG000NJ96L6,"Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain",2016-07-14 14:56:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tjuxm-X0Fr8/teva-teva-provides-2016-2019-outlook-shares-gain-cm649174,"Teva Pharmaceutical Industries Ltd.TEVA , which had raised its second quarter revenue and earnings guidance, held a call to discuss its preliminary outlook for 2016 2019 including the impact of the upcoming Actavis Generics acquisition. The company, which will"
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty Hit 11-month High",2016-07-14 07:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9VPdjcBjRb0/sensex-nifty-hit-11month-high-20160714-00246,"Sensex, Nifty Hit 11-month High"
RDY,RDY:US,BBG000NJ96L6,Looking For Generic Drug Stocks? Pick Up These Winners,2016-07-14 00:47:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vsh9SiRX0G8/looking-for-generic-drug-stocks-pick-up-these-winners-cm648946,The Zacks Industry Rank assigns a rating to each of the 265 industries based on their average Zacks Rank. An Industry with a larger percentage of Zacks Rank #1s (Strong Buy) and #2s (Buy) will have a better Zacks
RDY,RDY:US,BBG000NJ96L6,"Sensex Down 20 Points In Early Trade; Nifty At 8,512",2016-07-14 00:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/buZSQwucchc/sensex-down-20-points-in-early-trade-nifty-at-8512-20160714-00002,"Sensex Down 20 Points In Early Trade; Nifty At 8,512"
RDY,RDY:US,BBG000NJ96L6,Looking For Generic Drug Stocks? Pick Up These Winners,2016-07-13 22:27:10 +0000,http://finance.yahoo.com/news/looking-generic-drug-stocks-pick-222710146.html,Looking For Generic Drug Stocks? Pick Up These Winners
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's Laboratories Ltd (RDY) Ex-Dividend Date Scheduled for July 14, 2016",2016-07-13 13:25:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0wJc28_wBQs/dr-reddys-laboratories-ltd-rdy-ex-dividend-date-scheduled-for-july-14-2016-cm648503,"Dr. Reddy's Laboratories Ltd ( RDY ) will begin trading ex dividend on July 14, 2016. A cash dividend payment of $0.297353 per share Shareholders who purchased RDY prior to the ex dividend date are eligible for the cash"
RDY,RDY:US,BBG000NJ96L6,Teva Raises Guidance,2016-07-12 19:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wx6V18Z3nr8/teva-raises-guidance-20160712-01286,Teva Raises Guidance
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy's to Release Q1 FY17 Results on July 26, 2016 Earnings Call Slated for July 26, 6.30 PM IST / 9.00 AM EDT",2016-07-12 11:55:00 +0000,http://au.finance.yahoo.com/news/dr-reddys-release-q1-fy17-115500310.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy's Laboratories (NYSE: RDY | NSE: DRREDDY | BSE: 500124) will announce results for the First Quarter ended June 30, 2016 on Tuesday, July 26, 2016 after the ..."
RDY,RDY:US,BBG000NJ96L6,Interview With Value Activist Sandon Capital,2016-07-11 12:29:19 +0000,http://finance.yahoo.com/tumblr/blog-sandon-capital-122924908.html,[Yahoo Finance Contributors] - By Rupert Hargreaves Sign Up For Our Free Newsletter and receive in-depth ebooks on famous investors This is the final part
RDY,RDY:US,BBG000NJ96L6,Promius Pharma Launches New Corporate Brand Identity,2016-07-08 07:21:07 +0000,http://www.publicnow.com/view/76E4EB5928974193BCF2931975DDA69C71C00C6F,"[at noodls] - Microsoft Word - .docx Press Release Contact: INVESTOR RELATIONS Ashish Girotra ashishg@drreddys.com (Ph: +1 6093756145) MEDIA RELATIONS Lori McCreary lmccreary@drreddys.com (Ph: +1 6093752995) Princeton, ..."
RDY,RDY:US,BBG000NJ96L6,"Sensex, Nifty End Lackluster Session Marginally Higher",2016-07-07 07:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/THloOxTy4_w/sensex-nifty-end-lackluster-session-marginally-higher-20160707-00273,"Sensex, Nifty End Lackluster Session Marginally Higher"
RDY,RDY:US,BBG000NJ96L6,Sensex Closes Above 27000; Nifty Climbs Above 8300,2016-07-01 07:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GzA5CQ6ZuR0/sensex-closes-above-27000-nifty-climbs-above-8300-20160701-00172,Sensex Closes Above 27000; Nifty Climbs Above 8300
RDY,RDY:US,BBG000NJ96L6,DR REDDYS LABORATORIES LTD Financials,2016-06-29 17:04:28 +0000,http://finance.yahoo.com/q/is?s=rdy&annual,DR REDDYS LABORATORIES LTD Financials
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's Laboratories (RDY) Shares Cross Above 200 DMA,2016-06-29 16:47:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cqZh6_NLRdk/dr-reddys-laboratories-rdy-shares-cross-above-200-dma-cm642708,"In trading on Wednesday, shares of Dr. Reddy's Laboratories Ltd. (Symbol RDY) crossed above their 200 day moving average of $49.28, changing hands as high as $49.41 per share. Dr. Reddy's Laboratories Ltd. shares are currently trading up about"
RDY,RDY:US,BBG000NJ96L6,Asian ADRs Surge in Thursday Trading,2016-06-23 15:13:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iT5GFSIepAk/asian-adrs-surge-in-thursday-trading-cm639591,"American depository receipts of Asian stocks were trading 1.55% higher at 133.31 on the Bank of New York Mellon Asia ADR Index on Thursday. In North Asia, gainers were led by mobile game publisher Sky Mobi ( MOBI ),"
RDY,RDY:US,BBG000NJ96L6,Asian ADRs Edge Higher in Wednesday Trading,2016-06-22 14:56:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KOYFDqVYd8c/asian-adrs-edge-higher-in-wednesday-trading-cm638994,"American depository receipts of Asian stocks were trading 0.01% higher at 131.74 on the Bank of New York Mellon Asia ADR Index on Wednesday. In North Asia, te gainers were led by wealth management firm Jupai Holdings ( JP"
RDY,RDY:US,BBG000NJ96L6,Here’s Why These Five Stocks Are In the Spotlight,2016-06-13 13:07:23 +0000,http://www.insidermonkey.com/blog/heres-why-these-five-stocks-are-in-the-spotlight-2-459716/,Here’s Why These Five Stocks Are In the Spotlight
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s to acquire product portfolio from TEVA for US Market,2016-06-13 07:39:04 +0000,http://www.publicnow.com/view/420C52A4329C3FC1D7EB9D080BE4A6A71824BD6E,[at noodls] - 7c39c7e2-fa25-4795-8829-eb90d9fd3045.pdf Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS KEDAR UPADHYE kedaru@drreddys.com(Ph: +91-40-66834297) ... This is an abstract of the original noodl. To ...
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s to Buy Generics From Allergan, Teva for $350 Million",2016-06-11 13:56:39 +0000,http://www.bloomberg.com/news/articles/2016-06-11/dr-reddy-s-to-buy-generics-from-allergan-teva-for-350-million?cmpid=yhoo.headline,"Dr. Reddy’s to Buy Generics From Allergan, Teva for $350 Million"
RDY,RDY:US,BBG000NJ96L6,"Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan",2016-06-11 09:56:38 +0000,http://in.finance.yahoo.com/news/dr-reddys-buy-8-u-081954765.html,"Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan"
RDY,RDY:US,BBG000NJ96L6,"Promius Pharma Launches Sernivo™ (betamethasone dipropionate) Spray, 0.05% New Product For Mild to Moderate Plaque Psoriasis",2016-06-01 07:33:01 +0000,http://www.publicnow.com/view/52B3D83642A7E98DFF4064768484D292E424DF97,[at noodls] - Microsoft Word - FINAL Press Release - Promius Pharma Launches Sernivo (2).docx Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS KEDAR UPADHYE kedaru@drreddys.com(Ph: +91-40-66834297)... This is ...
RDY,RDY:US,BBG000NJ96L6,"Promius Pharma Launches Sernivo™ (betamethasone dipropionate) Spray, 0.05%",2016-06-01 06:48:00 +0000,http://au.finance.yahoo.com/news/promius-pharma-launches-sernivo-betamethasone-064800419.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories announced today that its US subsidiary, Promius Pharma, LLC, U.S. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), launched Sernivo™ (betamethasone dipropionate) Spray, 0.05% in the U.S. Sernivo Spray, a prescription topical steroid approved by the Food and Drug Administration (FDA) in February of 2016, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. “We are proud to bring Sernivo Spray to patients across the U.S.,” said Raghav Chari, Executive Vice President, Proprietary Products Group at Dr. Reddy’s Laboratories. Promius has conducted two multi-center, randomized, double-blind, vehicle-controlled clinical trials in subjects aged 18 years and older with moderate plaque psoriasis to evaluate the safety and efficacy of Sernivo Spray."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy's (RDY) Acquires Ducere Pharma's OTC Brands,2016-05-26 22:04:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S3CdbpDXkCg/dr-reddys-rdy-acquires-ducere-pharmas-otc-brands-cm627214,"Dr. Reddy's Laboratories Ltd . RDY announced that it acquired a portfolio of over the counter (OTC) brands in the cough and cold, pain and dermatology categories from Ducere Pharma. The brands acquired include Doans, Bufferin, Nupercainal ointmnent, Cruex"
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Enters the Branded Consumer Health Arena Through the Acquisition of Six OTC Brands,2016-05-25 10:47:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-enters-branded-consumer-104700396.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced the acquisition of an eminent portfolio of over-the-counter (OTC) ..."
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s enters the branded consumer health arena through the acquisition of six OTC brands,2016-05-25 10:26:08 +0000,http://www.publicnow.com/view/CF9D21821BF92091045A0A96CDAD2736C6C2DF45,[at noodls] - Microsoft Word - Press Release_ Dr Reddys US acquires six OTC brands.docx Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS KEDAR UPADHYE kedaru@drreddys.com(Ph: +91-40-66834297) ... This is an ...
RDY,RDY:US,BBG000NJ96L6,India eyes oil-for-drugs deal with Venezuela to recoup pharma cash,2016-05-18 14:25:29 +0000,http://sg.finance.yahoo.com/news/india-eyes-oil-drugs-deal-142426886.html,India eyes oil-for-drugs deal with Venezuela to recoup pharma cash
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Q4 and FY16 Financial Results,2016-05-12 15:17:05 +0000,http://www.publicnow.com/view/FD4BF618AA0D83F37BA710E6EE401624371E99F6,[at noodls] - 95dfc5e9-efc6-4995-ae41-ffe7be67ed95.pdf Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS KEDAR UPADHYE kedaru@drreddys.com(Ph: +91-40-66834297) ... This is an abstract of the original noodl. To ...
RDY,RDY:US,BBG000NJ96L6,India's Dr Reddy's sees more challenges in U.S. business,2016-05-12 14:44:03 +0000,http://in.finance.yahoo.com/news/dr-reddys-labs-fourth-quarter-101341216.html,India's Dr Reddy's sees more challenges in U.S. business
RDY,RDY:US,BBG000NJ96L6,Dr. Reddy’s Laboratories Announces the Appointment of Mr. Bharat Doshi as an Additional Independent Director on the Board of the Company,2016-05-11 17:14:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-laboratories-announces-appointment-171400174.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Mr. Bharat Doshi has been appointed as an Additional Independent Director on the Board of Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), effective May 11, 2016. Mr. Bharat Doshi is a Fellow Member of the Institute of Chartered Accountants of India and of the Institute of Company Secretaries of India, and holds a Master’s degree in Law from Bombay University. Mr. Doshi is a former Executive Director and Group CFO of Mahindra & Mahindra Limited, the flagship company of the Mahindra Group."
RDY,RDY:US,BBG000NJ96L6,Earnings Call Notification,2016-04-26 13:08:03 +0000,http://www.publicnow.com/view/28B1D0D03FBABCF91EF872019EBF9F55EB46A5A8,[at noodls] - Dr Reddy's Q4 FY16 v1 Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS KEDAR UPADHYE kedaru@drreddys.com(Ph: +91-40-66834297) ... This is an abstract of the original noodl. To continue reading ...
RDY,RDY:US,BBG000NJ96L6,Management Council,2016-04-25 11:15:06 +0000,http://www.publicnow.com/view/FE030E6628076A7F55255F863E1A1F04F27DFB8E,"[at noodls] - Our ensures that everything we do leads to perfect alignment - between our purpose of addressing patients' needs, and our business goals. Consisting of senior management members from various functions, ..."
RDY,RDY:US,BBG000NJ96L6,"ZEMBRACE™ SymTouch™ (Sumatriptan Injection) 3 mg, Approved by the FDA in January 2016 for the Acute Treatment of Migraine with or without Aura in Adults, is Now Commercially Available in the U.S.",2016-04-19 09:12:00 +0000,http://au.finance.yahoo.com/news/zembrace-symtouch-sumatriptan-injection-3-091200598.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Promius Pharma LLC, a subsidiary of Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced today that ZEMBRACE SymTouch is now commercially available in the U.S. ZEMBRACE SymTouch is a prefilled, low-dose, ready-to-use, 2-step autoinjector containing 3 mg of sumatriptan, a selective 5-HT1B/ID receptor agonist. Because ZEMBRACE SymTouch is a subcutaneous injection, it may lead to rapid relief of migraine."
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S, Europe and Certain Emerging Markets from Eisai",2016-03-31 10:03:19 +0000,http://www.publicnow.com/view/E26F6BDFC488FC3FFD18605E1183CFD90E68FC5A,[at noodls] - Microsoft Word - Dr Reddys and Eisai Press Release_Final_31st March Press Release CONTACT INVESTOR RELATIONS MEDIA RELATIONS KEDAR UPADHYE ... This is an abstract of the original noodl. To continue reading ...
RDY,RDY:US,BBG000NJ96L6,"Dr. Reddy’s Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S., Europe and Certain Emerging Markets from Eisai",2016-03-31 08:28:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-laboratories-acquires-rights-082800747.html,"[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has entered into a licensing agreement with Eisai Co., Ltd, Japan by which Dr. Reddy’s will be granted exclusive worldwide development and commercialization rights (excluding Japan and Asia) for Eisai’s investigational anticancer agent E7777. Eisai will be responsible for the development and marketing of E7777 in Japan and Asia, while Dr. Reddy’s holds the option for rights to develop and market the agent in India."
RDY,RDY:US,BBG000NJ96L6,Dr Reddy's expects emerging markets profit hit,2016-02-09 14:28:41 +0000,http://in.finance.yahoo.com/news/dr-reddys-q3-profit-lags-094001371.html,Dr Reddy's expects emerging markets profit hit
RDY,RDY:US,BBG000NJ96L6,India pharma investors think small as U.S. compliance woes hit heavyweights,2015-12-22 08:00:56 +0000,http://in.finance.yahoo.com/news/india-pharma-investors-think-small-080056872.html,India pharma investors think small as U.S. compliance woes hit heavyweights
RDY,RDY:US,BBG000NJ96L6,U.S. court imposes temporary sales ban on Dr Reddy's generic Nexium,2015-11-10 10:59:12 +0000,http://in.finance.yahoo.com/news/u-court-imposes-temporary-sales-105912063.html,U.S. court imposes temporary sales ban on Dr Reddy's generic Nexium
RDY,RDY:US,BBG000NJ96L6,Compliance worries hit shares in India's top two drugmakers,2015-11-09 07:50:25 +0000,http://in.finance.yahoo.com/news/compliance-worries-hit-shares-indias-075025494.html,Compliance worries hit shares in India's top two drugmakers
RDY,RDY:US,BBG000NJ96L6,"Dr Reddy's hit by FDA warning, shares fall 15 percent",2015-11-06 08:19:05 +0000,http://in.finance.yahoo.com/news/dr-reddys-gets-fda-warning-052122082.html,"Dr Reddy's hit by FDA warning, shares fall 15 percent"
RDY,RDY:US,BBG000NJ96L6,Dr Reddy's plans bigger push on biosimilars in emerging markets,2015-10-29 16:43:45 +0000,http://in.finance.yahoo.com/news/dr-reddys-plans-bigger-push-164345177.html,Dr Reddy's plans bigger push on biosimilars in emerging markets
RDY,RDY:US,BBG000NJ96L6,India risks missing boat as biosimilars shake up drug industry,2015-10-14 21:29:18 +0000,http://in.finance.yahoo.com/news/india-risks-missing-boat-biosimilars-210508191.html,India risks missing boat as biosimilars shake up drug industry
RDY,RDY:US,BBG000NJ96L6,Dr Reddy's institute launches interactive web portal,2015-08-29 14:48:03 +0000,http://in.finance.yahoo.com/news/dr-reddys-institute-launches-interactive-144803706.html,Dr Reddy's institute launches interactive web portal
RDY,RDY:US,BBG000NJ96L6,Dr Reddy's sees India sales growing 20 percent on new product launches,2015-04-10 06:47:23 +0000,http://in.finance.yahoo.com/news/dr-reddys-sees-india-sales-040748136.html,Dr Reddy's sees India sales growing 20 percent on new product launches
RDY,RDY:US,BBG000NJ96L6,"Sensex rises over 1 percent, posts first weekly gain in four",2015-04-01 13:39:28 +0000,http://in.finance.yahoo.com/news/bse-sensex-set-snap-three-094030379.html,"Sensex rises over 1 percent, posts first weekly gain in four"
RDY,RDY:US,BBG000NJ96L6,Dr Reddy's to buy some UCB brands for $128 million,2015-04-01 09:03:43 +0000,http://in.finance.yahoo.com/news/dr-reddys-buy-select-brands-071554917.html,Dr Reddy's to buy some UCB brands for $128 million
